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MRI can provide anatomical, functional, and physiological images at relatively 
high spatial resolution, is non-invasive and does not have depth limitation. However, the 
application of MRI to study the retina is difficult due to the very small size of the retina. 
This thesis details the development of MRI methods to image blood flow (BF), anatomy, 
and function of the retina and choroid, and their application to two diseases of the retina: 
diabetic retinopathy and retinal degeneration. 
A unique continuous arterial spin labeling technique was developed to image BF 
in mice and tested by imaging cerebral BF. This method was then applied to image layer-
specific BF of the retina and choroid in mice and to acquire BF functional MRI of the 
retina and choroid in response to hypoxic challenge. Additionally blood oxygen level 
dependent functional MRI of the mouse retina and choroid in response to hypoxic 
challenge was obtained using a balanced steady state free precession sequence which 
provides fast acquisition, has high signal to noise ratio, and does not have geometric 
distortion or signal dropout artifacts.  
In a mouse model of diabetic retinopathy, MRI detected reduced retinal BF in 
diabetic animals. Visual function in the diabetic mice, as determined by psychophysical 
tests, was also reduced. Finally, in a mouse model of retinal degeneration, BF and 
anatomical MRI detected reductions of retinal BF and the thickness of the retina. The 
studies detailed in this thesis demonstrate the feasibility of layer-specific MRI to study 
BF, anatomy, and function, in the mouse retina. Further, these methods were shown to 






MRI can provide anatomical, functional, and physiological images at relatively 
high spatial resolution and is non-invasive, does not have depth limitation, and provides 
excellent soft tissue contrast. MRI is widely used to study anatomy and physiology 
throughout the body due to these favorable properties. However, the application of MRI 
to study the retina is still difficult due to the very small size of the retina. The retina, 
which can be seen through the pupil, has thus traditionally been studied using optical 
techniques, some of which are limited to probing the retinal surface. 
In many diseases affecting various organs, the blood flow (BF) supply is known 
to be affected, or even an underlying cause of disease. Changes in the vasculatures and 
BF which nourish the retina are known to be important factors in retinal diseases such as 
diabetic retinopathy (1-4), glaucoma (5), and retinal ischemia (6). There is also some 
evidence of vascular damage in retinal degeneration (7-10).  
MRI has been used to image changes in cerebral BF in many different 
neurological diseases (11), such as stroke (12,13), brain tumor (14), Alzheimer’s disease 
(15,16), and epilepsy (17). MRI can image BF using arterial spin labeling (ASL) as well 
as functional changes and anatomy in the same setting. The application of MRI to study 
BF of the retina and alterations of BF in disease is quite challenging due to the high 
resolution that is necessary. 
This thesis describes the development of MRI methods to non-invasively image 
blood flow and anatomy of the retina and choroid in mice at high resolution and with 
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layer-specificity. These methods are applied to mouse models of two diseases, diabetic 
retinopathy and retinal degeneration. The rest of this chapter provides background 
information on the retina, MRI techniques, and imaging the retina. 
Chapter 2 describes the development of an MRI method to image quantitative BF 
in mice using continuous ASL, which provides excellent BF contrast. Continuous ASL 
using separate labeling and imaging coils in mice is difficult due to their small size which 
can result in saturation from the labeling coil, causing significant BF measurement errors. 
Two-coil continuous ASL was implemented in mice using a labeling coil placed at the 
heart, rather than the neck. This approach provides all the benefits of two-coil continuous 
ASL including, high labeling efficiency, ability for multi-slice acquisitions, and lack of 
magnetization transfer artifacts. This method was used to image basal cerebral BF (CBF) 
and CBF changes due to hypercapnia. 
 Chapter 3 describes the application of the cardiac ASL technique, described in 
Chapter 2, to image layer-specific BF of the retina and choroid in mice. High-resolution 
cardiac ASL was utilized to image quantitative, layer-specific retinal BF (rBF) and 
choroidal BF (chBF) in the mouse retina at 42x42x400 µm3 resolution. This method was 
then applied to acquire layer-specific BF functional MRI (fMRI) of the retina and choroid 
using hypoxic challenge as a stimulation. 
 Chapter 4 describes the application of a balanced steady state free precession 
(bSSFP) sequence to perform fMRI of the mouse retina and choroid. Most functional 
MRI studies use echo planar imaging sequences (EPI), but these sequences are prone to 
susceptibility artifacts due to magnetic inhomogeneity. EPI of the retina is particularly 
prone to these artifacts because the region around the eye is very inhomogeneous. bSSFP 
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sequences provide fast acquisition, have high SNR, and do not have geometric distortion 
or signal dropout artifacts associated with EPI. bSSFP imaging of the mouse retina and 
choroid was used to detect changes in blood oxygenation due to hypoxic challenge. 
Chapter 5 describes the application of high-resolution ASL MRI to image 
quantitative, layer-specific BF of the retina and choroid in the Ins2
Akita
 mouse model of 
diabetic retinopathy. Further, the vision of the diabetic mice was studied using 
psychophysical tests to determine changes of visual acuity and contrast sensitivity in 
diabetic mice. 
Chapter 6 describes the application of high-resolution MRI to anatomy and BF in 
the rd10 mouse model of retinal degeneration. MRI was utilized to image quantitative, 
layer-specific retinal and choroidal blood flow at different stages of degeneration. 
Anatomical MRI was also obtained to monitor changes in retinal and choroidal thickness 
over time. 
Chapter 7 summarizes the studies described in this thesis. 
1.1 Anatomy and Physiology of the Retina and Choroid 
1.1.1 Retinal Anatomy and Function 
The retina is a part of the central nervous system located at the back of the eye 
which converts light into nerve signals to produce vision (18). The retina consists of 
multiple structured anatomical layers (Figure 1.1). Starting from the outer layers of the 
retina and going towards the vitreous, anatomical layers of the retina are the retinal 
pigment epithelium, the inner and outer segments (IS and OS), outer nuclear layer 
(ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer 
(IPL), ganglion cell layer (GCL), and the nerve fiber layer (18). Behind the retinal 
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pigment epithelium are the choroid and sclera. The retina and choroid together are only 













Figure 1.1: Histological section of a mouse retina and its anatomical layers. Histology was 




The inner and outer segments consist of the rods and cones of the photoreceptors. 
The rods and cones are responsible for converting light to biochemical signals, through 
opsin proteins bound with retinal (20). Absorption of photons by retinal induces an 
isomerization, making the molecule able to activate transducin. The activated transducin 
then activates phosphodiesterase, which converts cyclic guanosine monophosphate 
(GMP) to GMP. Reduced cyclic GMP causes the closure of cyclic GMP gated cationic 
channels and hyperpolarization of the photoreceptor cell (20). 
The outer nuclear layer is made up of the cell bodies of the photoreceptors. The 
outer plexiform layer consists of synapses between the photoreceptors and other types of 
neurons in the inner nuclear layer. The inner nuclear layer consists of the cell bodies of 
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horizontal, bipolar, and amacrine cells, neurons of the retina. The inner plexiform layer is 
another synaptic layer, with connections between neurons of the inner nuclear layer and 
ganglion cells. The ganglion cell layer and nerve fiber layer primarily consist of the 
ganglion cells and their axons, neurons which transmit information from the retina to the 
optic nerve and brain (18). The retinal pigment epithelium is a thin layer of epithelial 
cells, which forms a barrier separating the neural retina from the choroid (18,21). The 
retinal pigment epithelium maintains the environment of the outer retina, supplying 
necessary molecules through active transport and removing waste products (18,21). 
1.1.2 Retinal and Choroidal Blood Flow 
The retina is nourished by two separate blood supplies, the retinal and choroidal 
circulations, located on either side of the retina (22,23). The retinal vessels are mainly 
localized on the inner surface of the retina, with arterioles and capillaries projected into 
the ganglion cell layer, inner plexiform layer, and inner nuclear layer. The choroidal 
vessels are located external to the neural retina in the choroid. The layers consisting of 
the photoreceptor cells (the outer nuclear layer and the inner and outer segments) and the 
outer plexiform layer are avascular, located in between the retinal and choroidal vascular 
layers (22). The retinal vessels mainly server the inner retina, while the choroidal vessels 
server the outer retina. The outer retina, which is avascular, receives oxygen mainly from 
the choroid by diffusion. Most of the oxygen of the inner retina comes from the retinal 
vasculature which has capillaries within the inner retina (22,24). 
The two vasculatures are quite different from each other. The choroid has very 
high vascular density, with among the highest BF and blood volume of any tissue. 
Choroidal blood flow (chBF) is many times greater than retinal blood flow (rBF) 
 6
(22,23,25,26). The reported ranges of chBF are around 7-19 ml/g/min (7,22), and rBF is 
reported to be around 0.2-0.9 ml/g/min (27,28). For comparison, rBF is generally similar 
to cerebral blood flow (CBF), while chBF is substantially higher (22). The high chBF is 
usually believed to be necessary to maintain a large oxygen gradient between the choroid 
and outer retina to drive oxygen diffusion into the outer retina (22,29). 
There is evidence that the two circulations may have different susceptibility to 
diseases and their deterioration may progress differently. For example, in a cat model of 
retinal degeneration, rBF is compromised whereas chBF is not significantly affected 
compared (7). In diabetic retinopathy, the choroidal and retinal blood vessels are 
anatomically abnormal and blood velocity decreases in retinal vessels in early phase in 
the streptozotocin-induced diabetic rat retina (1,30).  
1.1.3 Control of Retinal and Choroidal Blood Flow 
There are substantial differences in regulation of retinal and choroidal BF. The 
two vasculatures also respond differently to various physiological and blood flow 
regulating factors (22). The rBF is regulated locally by the metabolic needs of the tissue it 
perfuses. The chBF, which is separated from the outer retina - the tissue that it nourishes, 
is not regulated by the local metabolic of the outer retina. Increased oxygen causes 
decreased rBF (31,32), while having no effect on chBF (33,34). Hypoxia has also been 
found to cause rBF to increase (35). Hypercapnia causes both rBF and chBF to increase 
(32,33,36), and hypocapnia results in decreased retinal and choroidal BF (37).  
The retinal and choroidal vessels may also be regulated differently to changes in 
their perfusion pressure (22). The retinal vasculature is consistently reported to 
autoregulate in response to changes in perfusion pressure, either dilating or constricting, 
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to maintain BF (38,39). The choroid, however, is reported to lack autoregulation (36,40), 
but it is also reported to be autoregulated (41,42).  
 The choroid receives sympathetic and parasympathetic innervation, while the 
retinal vessels lack any direct nervous control (22,43). Stimulation of sympathetic nerves 
going to the eye causes vasoconstriction of choroidal vessels and reduces chBF, but does 
not affect rBF (22,43,44). Stimulation of parasympathetic nerves going to the eye 
increases chBF while not affecting rBF (22,45). 
1.2 Magnetic Resonance Imaging 
MRI uses a strong magnetic field to align the nuclear magnetization of nuclei 
(usually hydrogen protons), and then radiofrequency (RF) pulses are used to excite the 
nuclei (46). The excited nuclei produce an electromagnetic signal as they relax back to 
their equilibrium state, which is detected as the MR signal. Magnetic gradients are used 
to provide spatial information and to create an image. The MR signal is dependent on 
various tissue specific parameters, including proton density, longitudinal relaxation time 
(T1), and transverse relaxation time (T2). These MRI parameters vary depending on 
properties of the local tissue environment including water content, cellular structure, 
macromolecule content, and ion concentrations (46). The MR signal can be modified to 
produce images weighted by different parameters, such as blood oxygenation, blood 
flow, or blood volume. 
1.2.1 Blood Oxygenation Level Dependent Functional MRI 
Functional MRI can non-invasively image functional hemodynamic responses, 
based on changes in blood oxygenation. This technique is referred to as blood 
oxygenation level dependent (BOLD) fMRI (47). BOLD fMRI detects differences in MR 
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signal intensity that arise from changes in oxygen saturation of hemoglobin. 
Deoxyhemoglobin is paramagnetic and thus introduces intravoxel magnetic field 
inhomogeneity, while oxyhemoglobin is diamagnetic. The magnetic susceptibility 
difference between the paramagnetic deoxyhemoglobin and the surrounding tissues will 
alter the MR signal, so susceptibility-sensitized MRI images are able to show changes in 
regional deoxyhemoglobin content (48). A local reduction in deoxyhemoglobin 
concentration will increase the BOLD signal, while an increase in deoxyhemoglobin will 
decrease the BOLD signal (48). 
In the brain, when a specific region is activated due to stimulations, local blood 
flow increases to compensate for the increased metabolic activity and oxygen 
consumption in the region. Such blood flow increases will provide a boost in oxygen 
delivery in excess of the increased oxygen consumption associated with increased neural 
activities (49). Local oxygen saturation therefore increases and deoxyhemoglobin 
concentration decreases, causing an increase in the MR signal intensity. 
BOLD fMRI techniques have been used to study neurovascular coupling in the 
brain using physiologic challenges, such as hyperoxia, hypercapnia, and breath hold (50-
53). These stimuli modulate cerebral BF and oxygenation with little if any changes in 
neural activity and oxygen consumption. This provides valuable information regarding 
the integrity of neurovascular coupling, independent of changes in neural activity. 
1.2.2 Blood Flow MRI and Arterial Spin Labeling 
Two major MRI techniques have been developed to quantitatively image BF, 
dynamic susceptibility contrast in which an intravascular contrast agent is injected or 
arterial spin labeling (ASL) in which water in blood is magnetically labeled to provide 
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endogenous contrast. The half-life of exogenous contrast agents in blood is relatively 
long. This prevents the acquisition of multiple repetitions for time series analysis or 
averages to improve the signal to noise ratio of the blood flow data. The half-life of 
labeled blood in ASL, however, is on the order of the T1 of blood, which is about 2 s at 7 
Tesla (54). Therefore ASL can be repeated rapidly, every few seconds, allowing for 
averaging and time series acquisition.  
Two commonly used techniques for performing ASL are the continuous and 
pulsed methods (55-57). Continuous ASL uses a long RF pulse combined with magnetic 
gradients applied in the direction of flow to adiabatically invert moving spins as they 
flow past the labeling plane (58). In pulsed ASL, a short 180
o
 RF pulse is used to quickly 
invert blood within a large slab (59,60). Compared to pulsed ASL, continuous ASL 
generally provides better BF signal and contrast due to higher label efficiency (56,61). 
Continuous ASL however deposits more power into the subject and can be difficult to 
implement, limiting its use for human MRI.  
Continuous arterial spin labeling can be performed using the same coil or separate 
coils for labeling and imaging. The latter approach yields improved BF signal-to-noise 
ratio (SNR) with minimal magnetization-transfer if the imaging coil is decoupled while 
the labeling coil is transmitting. The two coil approach also easily allows multi-slice 
imaging which is otherwise difficult due to magnetization transfer in the single coil 
approach (56,61). 
Quantitative BF, in units of (ml of blood) / (g of tissue) / min, has been calculated 
from ASL MRI with a variety of strategies (62). Initially BF was calculated using 
modified Bloch equations to include the effect of inflowing spins in blood which have 
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been inverted by ASL with a single compartment model (58). This model assumes that 
water is freely diffusible tracer between blood and tissue. Blood flow using this model 












   (Eq. 1.1) 
 
where BF is quantitative blood flow values, MNL is the signal intensity of the non-labeled 
images and ML is signal intensity of the labeled images. λ is the tissue-blood partition 
coefficient of water, which is the ratio of water concentration of tissue to blood and is 





        (Eq. 1.2) 
 
λ has been measured by weighing wet and dry tissues to determine water content (64). 
Although λ varies from tissue to tissue, a whole brain average value of 0.9 is often used 
for quantification of CBF (64). Water content of various other tissues has been reported 
(65), including that of the neural retina (66). T1 is the longitudinal relaxation time of the 
tissue which is about 1.7-2.0 s in the brain and the retina at 7 Tesla (67,68). α is the 
labeling efficiency which can be measured experimentally using images acquired without 
labeling of blood and with optimally labeled blood (69,70). The optimal labeling power 










α       (Eq. 1.3) 
 
where the signal intensities MNL and ML are measured from a large artery in the image. 
Since the blood is being inverted, the sign of ML should be made negative in the 
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calculation to account for the fact that the value comes from the magnitude image. For 
perfect inversion, MNL and ML would be equal, giving a maximum value of α = 1. For 
saturation of the blood signal, as opposed to inversion, ML would equal 0 and α would be 
0.5.  
Other parameters that can affect quantification of BF include the transit time (δ), 
post labeling delay (w), and labeling duration (LD) (57). The transit time is the time 
needed for labeled blood to flow from the labeling site to the imaging site, and post 
labeling delay is a delay that is commonly inserted between the end of the labeling pulse 
and acquisition of images to allow labeled blood to flow out of large arteries and 
arterioles (57,71). These both introduce time during which labeled blood will undergo T1 
relaxation and can be compensated for in the BF calculation (62). For continuous ASL, 
the labeling duration should ideally be infinitely long, and the use of finite labeling pulses 
will cause BF to be underestimated. Finite labeling durations can be compensated for in 
the BF calculation as well (62,72). Including these other parameters, the BF can be 
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  (Eq. 1.4) 
 
where T1A is the T1 of arterial blood while T1 is the T1 of tissue and assuming w > δ. 
 BF quantification with ASL is prone to other errors including incomplete water 
exchange and venous outflow effects (55,57,73,74). It has been shown in the brain at 
least, that water is not entirely a freely diffusible tracer, which introduces some error into 
the calculation using the single compartment model (73,75,76). The water-exchange 
effect on BF quantification is complex, depending on the difference between blood T1 
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and tissue T1, blood flow rate, the extent of water exchange, magnetic field strength, BF 
measurement techniques, and BF calculation models (73,74). 
BF can be dynamically measured using ASL to determine BF changes in response 
to stimulations. Blood flow fMRI is more sensitive to BF in smaller vessels which better 
reflect local tissue perfusion and avoid contamination from large draining veins, which 
are prominent in typical BOLD fMRI (57). Moreover, BF fMRI is easier to interpret 
because it measures a single physiological parameter, in contrast to BOLD fMRI which is 
affected by multiple physiological parameters, such as blood flow, blood volume, and 
blood oxygenation. However, BF fMRI has lower temporal resolution and much lower 
SNR compared to BOLD fMRI (57,77). 
1.3 Methods of Studying the Retina and Choroid 
 In humans, the retina and choroid have been studied almost exclusively using 
optical methods. Optical methods are mostly non-invasive and can provide anatomical, 
functional, or physiologic information. Most optical techniques have limited depth 
resolution, and the choroid is often not studied being too deep to be probed by many 
methods. In animals, methods that are highly invasive or terminal have been used to 
study anatomical and physiological parameters that could not be measured through 
optical techniques. 
1.3.1 Optical Techniques 
Optical coherence tomography (OCT) has relatively deep tissue penetration and 
provides depth resolution, unlike most other optical methods (78). OCT is mostly used 
for anatomical imaging, providing very high-resolution images (resolutions of a few µm) 
with many distinct retinal layers images (79). Recently OCT has been adapted to study 
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blood velocity in vessels as small as capillaries (80,81). There are still some difficulties 
with blood velocity measurements such that only flow in the axial direction is detected 
(80).  
Angiography using intravascular dyes is clinically used to assess hemodynamics 
of the retina and choroid (22,82). Measurement of various hemodynamic parameters can 
be made. The mean transit time of a vessel is found from the concentration-time curves of 
the dye bolus. The arteriovenous passage time can be measured as the time for the dye to 
pass from the arteries to veins (22,82). Additionally, the velocity of the dye moving 
through a vessel can be measured from the distance traveled by the dye in successive 
frames (82). Fluorescein angiography is commonly used to study the retinal vasculature 
(83). Indocyanine green, another dye, fluoresces at a wavelength that passes through the 
retinal pigment epithelium, so it is used for angiography of the choroidal vessels (84). 
Angiographic techniques are slightly invasive since they require intravascular injections 
of dye. Although quantitative measurements can be made, they are limited to large 
vessels such as arteries and arterioles. They also lack depth resolution, so distinguishing 
retinal and choroidal vessels when using indocyanine green can be somewhat difficult. 
Laser Doppler velocimetry is used to measure the quantitative velocity of blood 
cells flowing through large vessels (82,85,86). Laser Doppler velocimetry detects the 
Doppler frequency shift of the light due to moving erythrocytes in the blood. A fundus 
image taken with some other device can be used to measure vessel diameter and estimate 
cross-sectional area of the vessel, and used in combination with laser Doppler 
velocimetry, the blood flow through the vessel can be calculated (82,86). Laser Doppler 
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velocimetry can only be performed on large vessels on the inner surface of the retina and 
only provides measurements at discrete points.  
Laser Doppler flowmetry is similar to Laser Doppler velocimetry, but the laser is 
directed at tissue, detecting moving erythrocytes in microvasculature perfusing the tissue 
(34,87). Laser Doppler flowmetry provides non-quantitative measures of tissue perfusion 
(87). Thus, laser Doppler flowmetry is often used to detect functional changes in BF due 
to stimulations. Due to the lack of depth resolution, the laser Doppler flowmetry signal 
will be some unknown combination of signals from the retina and choroid (87). Laser 
Doppler flowmetry is often performed at the fovea, which lack retinal vessels to report 
chBF (33,34). 
Laser speckle imaging determines relative BF in a tissue based off fluctuations in 
interference patterns of scattered light due to moving red blood cells (88,89). Laser 
speckle imaging can provide relative BF images of the retinal surface, but is mostly used 
to study functional BF changes during stimulations due to difficulty in quantification 
(89). Laser speckle imaging lacks depth resolution, making separation of retinal and 
choroidal signals difficult. 
1.3.2 Non-optical Techniques 
The microsphere technique using intravascular injection of radioactively or 
fluorescently labeled microspheres has been used to study quantitative BF of the retina 
and choroid in animals (40,90). Intravascularly injected microspheres become embedded 
in capillary beds in proportion to the rate of BF to the tissue. Blood flow can be 
determined by measuring the amount of radiation, fluorescence, or counting the number 
of spheres in a tissue (40). Microspheres can only be used in terminal experiments, since 
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the organ of interest must be removed for analysis. Also, functional studies are difficult 
using microspheres since multiple doses of differently labeled spheres must be injected 
before and after stimulation, but repeated doses of microspheres can change BF and 
animal physiology (35,37). 
Blood flow and tissue oxygenation having been studied using electrodes inserted 
through the eye and into the retina and choroid. BF can be determined by measuring the 
clearance of hydrogen from the tissue (91,92). Oxygen tension in tissues can also be 
measured using microelectrodes (93,94). Electrode based measurements only measure 
local information at the location of the electrode. The exact location of the electrode tip 
cannot be known for certain. Local inhomogeneities of the tissue around the electrode can 
significantly affect the measurement. For example, the electrode being nearby an artery 
or arteriole will give much different readings than if there were nothing but tissue nearby 
(95).  
1.4 Previous MRI Studies of the Retina and Choroid 
Optical techniques require an unobstructed light path, so eye diseases such as 
vitreal hemorrhage and cataract may preclude the use of optical techniques. Optical 
techniques used to study blood flow and physiology are generally qualitative or the 
signals are measured from individual blood vessels which may not accurately reflect local 
tissue perfusion. Additionally, most optical techniques, aside from OCT, lack depth 
resolution, so distinguishing signals from the retina or choroid is difficult.  
 In recent years, high-resolution laminar-specific MRI of the retina and choroid 
has been used in animals. Methods to image anatomy, BF, and BOLD functional changes 
have been reported. MRI methods which can non-invasively image physiology and 
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function of the retina and choroid without depth resolution could help to better 
understand how these two vascular layers are regulated in health and disease, improving 
understanding of pathophysiology in vivo.  
1.4.1 Anatomical MRI of the Retina 
 Anatomical MRI has been used to image multiple layers of the retina and choroid. 
Using gradient echo and spin echo sequences, 3 retinal layers, including the choroid have 
been detected in cats (96) and rats (9), and 4 retinal layers have been detected in mice 
(19). Intraocular injection of the MRI contrast agent manganese chloride has been used to 
enhance anatomical layer contrast, providing images with 7 retinal layers, including the 
choroid (97). Finally, measurement of MRI parameters affecting anatomical image 
contrast, including T1, T2, and the apparent diffusion coefficient of water have been 
measured in cats (96), rats (68), and mice (19). 
1.4.2 Functional MRI of the Retina 
 BOLD fMRI of the retina has been performed to visual and physiological 
stimulations. In both cats and rats, a positive BOLD signal has been detected in the retina 
in response to visual stimuli (98,99). These studies were performed at relatively low 
resolution, so the source of the response, the retinal or choroidal vasculature, could not be 
localized. BOLD fMRI in response to hypercapnia and hyperoxia has been performed in 
rats (9). Different responses could be detected on the inner and outer edges of the retina, 
likely corresponding to the retinal and choroidal vasculatures, respectively. However, the 
resolution was relatively low, making separation of the layers not entirely clear. 
Additionally, the BOLD changes in response to hypercapnia and hyperoxia were found to 
be attenuated in a rat model of retinal degeneration (9). 
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1.4.3 Blood Flow MRI of the Retina 
 
 Blood flow MRI and fMRI of the retina has been reported in rats using ASL 
(8,100). In these studies, the resolution was too low to distinguish retinal and choroidal 
BF. There was only a single BF layer of the combined retina and choroid. BF fMRI in 
response to hypercapnia and hyperoxia was also demonstrated in rats. BF of the 
combined retina/choroid was found to increase in response to hypercapnia and decrease 
in response to hyperoxia (100). BF MRI of a rat model of retinal degeneration found 
basal BF of the combined retina/choroid to be decreased (8). BF fMRI in response to 
hypercapnia and hyperoxia was also performed in the rat model of retinal degeneration. 
The magnitude change in quantitative BF was attenuated in the disease rats, but the 
percent BF change was not altered (8). BF of the combined retina/choroid has also been 
reported using MRI in humans, but at much lower resolution (101,102). The BF values 
reported in human so far are much lower than chBF reported in animals with invasive 
techniques. A likely reason for this is the low resolution ASL MRI used in humans results 
in substantial partial volume of the choroid and tissues with low BF, reducing the 
measured BF value. 
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CHAPTER 2 
CONTINUOUS ARTERIAL SPIN LABELING IN MICE  
APPLIED TO CEREBRAL BLOOD FLOW 
 
While continuous ASL using a separate neck labeling coil has been employed in 
rats (13,103), humans (69), and monkeys (70,104), its extension to mice had not yet been 
reported. Mice are widely used in biomedical research, and there exists many disease 
models available in mice, with new transgenic and knockout mouse models frequently 
created. As such, a method to accurately measure blood flow (BF) in mice in vivo with 
high resolution and good signal to noise ratio (SNR) could provide unique information 
about the underlying physiology or causes of numerous diseases, such as stroke (13), 
Alzheimer’s disease (15,16,105), or diabetic retinopathy (1,30,106). 
 A possible reason for the absence of continuous ASL in mice is due to their small 
size which results in proximity of the labeling coil and imaging brain coil, separated by 
only about 1 cm from center to center. This causes significant saturation of the brain 
signal by the neck coil, causing significant CBF measurement errors. This occurs even 
when the coils are actively decoupled, coil sizes are minimized, and inter-coil distance is 
maximized. BF imaging in mice using other MRI techniques is sparse and only a few 
CBF studies using the single-coil ASL method (107-111) and the dynamic susceptibility 
contrast method (112,113) have been reported. These previous studies seem to suffer 
from limitations of these techniques, such as single slice acquisitions, low labeling 
efficiency, or low BF contrast and SNR. 
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To overcome the above limitations, two-coil continuous ASL was implemented in 
mice using a labeling coil placed at the heart, rather than the neck. The separation of the 
labeling coil and imaging slices is large enough (about 2 cm for the brain) to avoid 
saturation of brain tissue by the labeling coil. This approach provides all the benefits of 
two-coil continuous ASL, including high labeling efficiency, ability for multi-slice 
acquisitions, and lack of magnetization transfer artifacts. Cardiac ASL was used to image 
basal CBF and CBF changes due to hypercapnia. 
2.1 Methods 
Animal preparations: Mice (C57BL/6, 6-10 weeks, n = 5) were imaged under 
1.2% isoflurane and spontaneous breathing conditions. Under baseline, 30% O2 with 
balance nitrogen was supplied to the mice. Animals were placed in an animal holder with 
ear and tooth bars. Respiration rate (80-130 breaths/min) and rectal temperature (37 ± 0.5
o 
C) were monitored and maintained within normal physiological ranges. 
MRI methods: MRI studies were performed on a 7 Tesla, 30 cm magnet and a 150 
G/cm BGA6S gradient insert (Bruker, Billerica, Massachusetts). A custom-made, circular 
surface coil (diameter = 1.1 cm) with active decoupling was placed on top of the head. A 
circular labeling coil (diameter = 0.8 cm), built into the holder, was placed at the heart 
position for cardiac ASL. The two coils were positioned parallel to each other and were 
separated by about 2 cm from center to center.  
BF MRI was acquired using ASL with a gradient-echo EPI sequence. Paired 
images, one with and one without labeling, were acquired in an interleaved fashion. The 
cardiac ASL employed a 2.1 s square radiofrequency pulse to the labeling coil in the 
presence of 2.0 G/cm gradient and a post labeling delay of 1.4 ms. The sign of the 
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frequency offset was switched for non-labeled images. Other MRI parameters were: field 
of view = 12.8x12.8 mm
2
, matrix = 64x64 (single-shot EPI) or 128x128 (four-shot EPI), 
slice thickness = 1 mm, 9 slices, TR = 2.6 s per segment, and TE = 10 ms.  
Labeling efficiency was measured at the distal internal carotid arteries at the base 
of the frontal lobe using a fast low angle shot (FLASH) acquisition. Sequence parameter 
were: field of view = 11x8 mm
2
 or 11x11 mm
2
, matrix = 128x128, slice thickness = 1 
mm, TE = 4.57 ms, 1 slice, labeling duration = 300 ms, 5-7 variable powers for the 
labeling pulse, and TR = 313 ms. The short TR was used to saturate static brain signal for 
better delineation of the blood vessels while steady-state labeling could still be achieved 
in large arteries. 
Hypercapnic challenge: Hypercapnic challenge used premixed gas of 5% CO2 
with 30% O2 and balance N2. The baseline consisted of 30% O2 with balance N2. Each 
trial consisted of a 6 or 7 min scan, with baseline conditions during the first half of the 
trial and hypercapnia during the second half. A 10 min break was given between trials for 
the animals to return to normal physiologic conditions. Two to four repeated 
measurements for each gas condition were typically made. 
Data analysis: Image analysis was done using Matlab (MathWorks Inc, Natick, 
MA) and STIMULATE software (University of Minnesota). Basal CBF data were 
derived from measurements under baseline conditions. Blood flow images, in units of 
ml/g/min, were calculated pixel-by-pixel using Eq. 1.1. The water tissue-blood partition 
coefficient λ was taken to be 0.9 (64). Whole brain average T1 at 7 T was taken to be 1.7 
s (67). A value of 0.73 was used for the labeling efficiency α, as measured for cardiac 
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ASL. The labeling efficiency was calculated from Eq. 1.3 using the arrayed labeling 
power data. 
To analyze BF fMRI changes to hypercapnia, the CBF time-course was calculated 
using pair wise subtraction of consecutive non-labeled and labeled images. The percent 
change in CBF between baseline and hypercapnia was then calculated.  
 2.2 Results 
2.2.1 Basal Cerebral Blood Flow 
The schematic of the cardiac ASL setup is shown in Figure 2.1. Quantitative CBF 
analysis employed regions of interest, including the whole brain, frontal cortex, sensory-
motor cortex, corpus callosum, hippocampus, caudate putamen, thalamus, inferior 
colliculus, superior colliculus, pons, and cerebellum. Labeling efficiency was measured 





Figure 2.1: Set-up for cardiac ASL to image CBF in mice, showing the imaging and labeling 
coils, as well as the animal holder. The two coils are separated by about 2 cm, center-to-center. 





Quantitative CBF images at 200x200 µm2 and 100x100 µm2, shown in Figure 2.2, 
have heterogeneous blood flow contrast as expected. CBF is lower in the corpus callosum 
(white matter) compared to gray matter. CBF in the cerebellum and brain stem could be 
imaged, in contrast to two-coil ASL CBF in rats where the cerebellum and brain stem are 
often not reported due to saturation artifacts by the neck labeling coil. The whole-brain 
CBF was 1.07 ± 0.08 ml/g/min (mean ± SD, n = 5). Regional CBF values at 100x100 
µm2, obtained from different regions of interest (shown in Figure 2 C) are summarized in 

























Figure 2.2: Quantitative CBF maps (in ml/g/min) from a normal mouse at (A) 100x100x1000 
µm3 and (B) 200x200x1000 µm3. Slices go from posterior to anterior. (C) The regions of interest 
used for regional CBF analysis overlaid on T2 weighted anatomical images. 1. frontal cortex, 2. 
sensory-motor cortex, 3. caudate putamen, 4. thalamus, 5. hippocampus, 6. corpus callosum, 7. 
cerebellum, 8. superior colliculus, 9. inferior colliculus, 10. pons. Adapted from Muir et al., Magn 




Table 2.1: Regional CBF in mice from 100x100x1000 µm3 images (mean ± SD, n = 5). Adapted 
from Muir et al., Magn Reson Med 2008, (114). 
Region of Interest CBF (ml/g/min) 
Whole brain 1.07 ± 0.08 
1. Frontal cortex 1.00 ± 0.14 
2. Sensory-motor cortex 0.92 ± 0.14 
3. Caudate putamen 1.08 ± 0.06 
4. Thalamus 1.18 ± 0.08 
5. Hippocampus 1.28 ± 0.08 
6. Corpus callosum 0.53 ± 0.10 
7. Cerebellum 1.08 ± 0.15 
8. Superior colliculus 1.18 ± 0.15 
9. Inferior colliculus 1.51 ± 0.42 
10. Pons 1.40 ± 0.21 
 
 
2.2.2 Cerebral Blood Flow Changes During Hypercapnia 
The CBF fMRI time course during hypercapnic challenge from a single 
measurement in one animal is shown in Figure 2.3. The group-averaged hypercapnia-




Figure 2.3: Time-course of CBF percent change due to hypercapnia from a single mouse. Five 
percent CO2 was switched on half way through the trial as shown by the gray bar. Adapted from 





Cardiac ASL provides a practical approach to image quantitative CBF and 
physiologically evoked CBF changes in mice with the high sensitivity of continuous 
ASL. This technique overcomes existing limitations and offers the following advantages: 
1) Multi-slice, quantitative, high-resolution CBF images and CBF fMRI can be obtained 
with high sensitivity without magnetization-transfer effect. 2) The distance between the 
heart and the brain in mice avoids saturation of the brain signal by the label coil. 3) CBF 
of the cerebellum and brain stem can be imaged in contrast to two-coil ASL in rats where 
the cerebellum and brain stem are often not reported due to saturation artifacts by the 
neck labeling coil. Moreover, BF MRI in other body parts within reasonable transit time, 
such as the kidneys and liver, might be possible. With a neck coil labeling which labels 
only the carotid arteries, this would not be possible. Cardiac ASL MRI has the potential 
to broaden BF MRI utility in mice and other similar size species. 
2.3.1 Cardiac Arterial Spin Labeling Applied to Cerebral Blood Flow 
Labeling efficiency: Labeling efficiency was measured to be 0.73 ± 0.06, 
consistent with many published data, with reported values of about 0.7 at 1.5 and 3 Tesla 
(69,115,116), 0.75 at 4.7 Tesla (117), and 0.8 at 9.4 Tesla (118). The labeling efficiency 
for cardiac ASL in mice was measured at imaging planes positioned at the brain, as 
opposed to the carotid arteries in the neck. Thus, the labeling efficiency measurement 
includes the T1 relaxation of the blood due to the transit time. Assuming transit time is 
relatively constant between animals, this avoids the need for measuring transit time, 
which is difficult to do.  
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In initial measurements of labeling efficiency in the carotid arteries under the 
cerebellum, the labeling efficiency was fairly low, about 0.63. Labeling efficiency was 
measured at three different slice positions in the posterior-anterior axis, ranging from the 
carotid arteries under the cerebellum to the distal internal carotid arteries under the 
frontal lobe (covering about a 7 mm range). Labeling efficiencies increased from 0.63 at 
the carotid arteries under the cerebellum to 0.73 at the distal internal carotid arteries in 
the center and anterior slices. This indicated that at higher labeling powers, some 
saturation was present in the posterior due to the cardiac labeling coil. Labeling 
efficiency thus had to be measured at the distal internal carotid arteries, which had no 
noticeable saturation effects from the cardiac labeling coil.  
Blood flow calculation: Quantitative CBF measurement by MRI is susceptible to 
errors. The main sources of errors include magnetization-transfer (119,120), transit-time 
(121,122) and water-exchange effect (74,123). Magnetization-transfer effect was not an 
issue for continuous ASL herein because a separate labeling coil with active decoupling 
of the imaging coil was used. Although transit time was not explicitly taken into account 
in the calculation of CBF herein, the measurement of labeling efficiency at the brain 
should account for T1 relaxation of labeled blood during the transit to the imaging slices. 
Additionally, transit time has been shown to have minimal effects on quantification of 
CBF in rats because of the small distances and short transit times (124). Because of the 
multi-slice acquisition, different image slices may have slightly different transit time, but 
again this should be minimal due to the small size of rodents and rapid EPI acquisition. 
The single compartment model used in CBF calculation assumes that all blood water 
exchanges into the tissue, which is not true. Water-exchange effect is generally more 
 26
significant in white matter than in gray matter because of its larger T1 difference from 
blood T1 (74). It has been shown that water-exchange effects and venous outflow are at 
least partly compensated by the presence of labeled blood in the capillary space (74). 
Comparison of different CBF quantification models, including those accounting for water 
exchange across the blood-brain barrier, indicates that CBF values obtained using 
different models were overall similar although there are some distinct differences (62). 
Quantitative CBF in mice: The group-average whole-brain CBF in mice was 1.07 
± 0.08 ml/g/min under 1.2% isoflurane. This is consistent with CBF values in rats, which 
ranged from 0.76 to 1.1 ml/g/min (52,125), that were obtained using continuous ASL 
MRI with a separate neck coil obtained under essentially identical experimental 
conditions. Quantitative CBF in mice has also been reported using destructive techniques, 
predominantly iodoantipyrine autoradiography. CBF from these methods was 0.99-1.59 
ml/g/min under 1.0% halothane (126), 0.5-1.0 ml/g/min under equithesin anesthesia 
(127). These values are similar to the cardiac ASL measurements in mice. 
However, CBF values from cardiac ASL in mice are lower compared to single-
coil ASL techniques in mice, with values of 1.7-2.8 ml/g/min under 2% isoflurane (108) 
and 1.5-2.0 ml/g/min under 1% halothane (107). These single-coil approaches imaged 
one slice at comparatively lower spatial resolution. It is important to note that isoflurane 
is a known vasodilator. Previous studies have shown that rat CBF under 1% isoflurane 
anesthesia was substantially higher than under awake conditions in the same animals 
(128) and under α-chloralose in separate animals (129). Moreover, increasing isoflurane 
from 1% to 2% has been reported to increase CBF from 0.87 ± 0.27 to 1.31 ± 0.30 
ml/g/min in the same animals (130). Halothane has been reported to be have a stronger 
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vasodilatory effect than isoflurane in humans (131) and rats (132). The discrepancy 
between cardiac ASL and single-coil ASL techniques could be due to methods, including 
CBF model equation, and anesthetics.  
2.3.2 Cerebral Blood Flow Changes During Hypercapnia 
The CBF percent change was found to be 33 ± 16 % during hypercapnia. Using 
pulsed ASL in isoflurane-anesthetized mice, carbogen (95% O2 and 5% CO2) has been 
found to increase CBF by 14-30%, compared to 100% O2 (133). Hypercapnia-induced 
CBF changes in mice, as measured by laser speckle flowmetry, have been reported to 
increase 40-55% under α-chloralose (134), 15% under 1% isoflurane (134), and 60-75% 
under urethane/α-chloralose (135). In rats, hypercapnia-induced CBF increase has been 
reported as 60%, using MRI (52) and under essentially identical experimental conditions 
as used herein for mice. The hypercapnia-induced CBF increase from cardiac ASL is 
higher than measurements made in mice with laser speckle flowmetry made under 
isoflurane but lower than in rats under isoflurane with MRI. Comparison to 
measurements made under different anesthetics is difficult since isoflurane is known to 
reduce vascular responses (134). 
2.4 Conclusions 
The cardiac ASL method provides a practical approach to image whole-brain 
CBF in mice in vivo with excellent BF contrast and SNR. Previous reports of CBF in 
mice acquired with MRI were limited to a single slice due to the use of a single coil, but 
the two-coil cardiac ASL method could provide whole-brain CBF, including the 
cerebellum and brain stem. Signal-to-noise ratio, spatiotemporal resolution, multi-slice 
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and fMRI capability of cardiac ASL MRI compare favorably with existing approaches for 
mice. This approach could provide a valuable tool to study numerous brain disease and 
transgenic models available in small animals, including stroke and Alzheimer’s disease. 
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CHAPTER 3 
LAYER-SPECIFIC BLOOD FLOW OF THE  
MOUSE RETINA AND CHOROID 
 
The retina is nourished by two distinct circulations, the retinal vessels within the 
inner retina and the choroid vessels behind the neural retina. The outer nuclear layer and 
the inner and outer segments of the photoreceptors in between are avascular (22). There 
are substantial differences in basal blood flow (BF) and regulation of BF between the two 
blood supplies (22,25,26,34,35,37), so it is important to be able to distinguish the two 
vasculatures in studying BF to the retina. This requires that any technique used has no 
depth limitation and high resolution. BF imaging with ASL MRI is quantitative, not-
depth limited, and is non-invasive. However, ASL is limited by low SNR and low 
resolution, so its application to layer-specific BF imaging of the retina and choroid is 
challenging. 
 The continuous ASL technique with cardiac labeling proved capable of imaging 
cerebral BF (CBF) in mice with good SNR and BF contrast in relatively short time (114). 
Thus, this technique was promising for BF studies of the mouse retina. High-resolution 
cardiac ASL was utilized to image quantitative, layer-specific retinal BF (rBF) and 
choroidal BF (chBF) in the mouse retina at 42x42x400 µm3 resolution. Basal BF in the 
retina and choroid was measured under two anesthetic regimens – isoflurane, a 
vasodilatory anesthetic (136), and ketamine/xylazine, a vasoconstrictive anesthetic 
cocktail (137,138) – to test the sensitivity of ASL MRI to detect differences in BF. This 
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method was then applied to acquire layer-specific BF fMRI of the retina and choroid 
using hypoxic challenge as a stimulation. 
3.1 Basal Blood Flow of the Retina and Choroid 
3.1.1 Methods 
Animal preparation: Experiments were performed on C57BL/6 mice (4 female, 3 
male, 5-11 weeks old, 17-28 g, n = 7). Animals were anesthetized with isoflurane, put 
into a head holder with ear and tooth bars, and placed in an animal holder with a 
circulating warm water pad. An intraperitoneal line was placed in the animal to 
administer drugs during MRI without moving the animal. Imaging was performed first 
under 1.1% isoflurane and spontaneous breathing conditions. In the same animals, 
anesthesia was subsequently switched to ketamine - xylazine (100 mg/kg - 10 mg/kg, 
intraperitoneal) and isoflurane was discontinued. MRI was repeated 10 min after 
switching of the anesthetics. Air and oxygen were mixed to provide 30% O2 to the 
animals during imaging under both anesthetics. MRI under isoflurane was performed first 
in all mice because its half-life is much shorter compared to ketamine/xylazine, allowing 
the two anesthetics to be studied on the same animals in the same setting within 
reasonable time, thereby reducing inter-subject variation.  
Respiration rate was monitored and was ~115 breaths/min under isoflurane and 
~95 breaths/min under ketamine/xylazine. Rectal temperature was monitored and 
maintained at 37 ± 0.5° C. Mice were prepared in a lit room before being transferred to 
the MRI room, in which lights were turned off. Lighting conditions were not changed 
during the duration of imaging. Additionally, some mice (n = 4) were euthanized in the 
 31
scanner after in vivo experiments with sodium pentobarbital (250 mg/kg, intraperitoneal) 
and BF imaging repeated a few minutes after respiration ceased. 
MRI methods: MRI studies were performed on a 7 Tesla, 30 cm horizontal 
magnet and a 150 G/cm BGA6S gradient insert (Bruker, Billerica, Massachusetts). For 
imaging, a small circular surface eye coil with active decoupling (diameter = 6 mm) was 
placed over the left eye. A circular labeling coil (diameter = 8 mm) was placed at the 
heart position for a cardiac ASL technique (114). The two coils were separated by about 
2.3 cm from center to center.  
BF MRI was acquired using two-coil continuous ASL with an echo planar 
imaging (EPI) sequence. Paired images, one with and one without labeling, were 
acquired in an interleaved fashion. ASL employed a 2.94 s square radio frequency pulse 
to the labeling coil in the presence of 2.0 G/cm gradient along the flow direction with a 
post label delay of 10 ms. The sign of the frequency offset was switched for non-labeled 
images. 
Images were acquired in a coronal orientation with a single slice passing through 
the retina at the optic nerve head, with the slice angled perpendicular to the retina. Two-
segment, gradient-echo EPI was used with field of view = 6.0x6.0 mm
2
, matrix = 
144x144 (42x42 µm2 resolution), a single 0.4 mm slice, TR = 3.0 s per segment, and TE 
= 13 ms. For each scan, seventy-five pairs of images were typically acquired in time-
series (to be averaged off line) with a total acquisition time of 15 min.  
Data analysis: Image analysis was done using codes written in Matlab (Math-
Works, Natick, MA), STIMULATE software (University of Minnesota), and Statistical 
Parametric Mapping 5 (SPM5) software. Images were zero-padded to 256x256 (nominal 
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resolution of 23x23 µm2) before Fourier transform into imaging space. All images from 
each scan were acquired as time series, aligned using the spatial realignment function in 
SPM5 and averaged off line.  
BF images of the eye, in units of ml/g/min, were calculated pixel-by-pixel using 
Eq. 1.1. λ, the water tissue-blood partition coefficient, was taken to be 0.9, the same as 
the brain (64). λ, a difficult measurement, has not been reported for the retina or choroid. 
The retina and choroid T1 at 7 Tesla was taken to be 1.8 s (68) which is similar to brain 
T1. A value of 0.7 was used for α, the labeling efficiency, as was previously measured in 
the distal internal carotid arteries at the base of the frontal lobe (see Chapter 2) (114). 
BF intensity profiles across the retinal thickness were obtained from BF images 
by radially projecting lines perpendicular to the retina (9,139) with profiles obtained at 4x 
spatial interpolation. Figure 3.1 demonstrates the steps in the profile analysis of the 
retina. BF profiles were averaged along the length of the retina. Measurements of peak 
values and layer thicknesses – defined as the half-height width of peaks – were 
determined from the average BF profiles for each animal.  
Since there was no BF after death, post-mortem BF measurements were made by 
aligning post-mortem anatomical profiles to the anatomical profiles obtained under 
isoflurane. The locations of rBF and chBF peaks were determined from the isoflurane BF 
profile. rBF and chBF were measured from the post-mortem BF profile by averaging over 
nine pixels centered at the respective BF peak. Group-average data were expressed as 
mean ± SD. Statistical analysis of BF data used two-sided, paired t-tests. Analysis of 






Figure 3.1: Profile analysis of BF MRI data. The image on the left shows an EPI image of the 
eye.  The blue lines on the left image show the profiles taken perpendicularly to the retina. The 
profiles can then be used to create a linearized representation of the retina, including anatomy and 
BF images (center images). All the profiles consisting of the linearized retina can be averaged, to 




With a resolution of 42x42x400 µm3, two distinct BF layers in the retina were 
resolved, separated by a region of no BF contrast (Figure 3.2 A). The outer BF layer, 
which corresponds to the choroid, had very high BF. The inner BF layer, which 
corresponds to the retinal vessels, had substantially lower BF than the choroid. The 
middle layer with little to no BF contrast corresponds to the avascular region – made up 
of the outer nuclear layer and the outer and inner photoreceptor segments. BF signals in 
the ciliary bodies and extra-ocular tissue were also detected sometimes, although not 
clearly or consistently due to susceptibility-induced signal dropout in the anterior regions 
of the eye. No statistically significant BF signal was detected in the vitreous or lens (p > 
0.05, one sample t-test comparing the sample mean to 0, n = 7). Figure 3.2 B shows a BF 
image obtained from the same mouse post-mortem. No BF contrast was detected in the 
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dead animals (p > 0.05 for both rBF and chBF, one sample t-test comparing the sample 
mean to 0, n = 4), suggesting that BF was the source of signals in vivo. The BF profiles 
in Figure 3.2 C show two BF layers distinctly separated by an avascular region in the live 
mouse and the absence of BF contrast in the dead mouse retina.  
 
 







































Figure 3.2: (A) Layer-specific blood flow image from a mouse under 1.1% isoflurane. (B) Blood 
flow acquired in the same mouse after euthanasia. (C) Blood flow profiles from the images in (A) 
and (B). chBF – choroid blood flow, rBF – retinal blood flow. Adapted from Muir et al., NMR 




Layer-specific BF measurements were made under isoflurane (Figure 3.3 A) and 
ketamine/xylazine (Figure 3.3 B). Group-averaged BF profiles under each anesthetic are 
shown in Figure 3.3 C. Retinal BF and chBF were both substantially lower under 
ketamine/xylazine compared to isoflurane. 
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Figure 3.3: Blood flow image in a mouse under (A) 1.1% isoflurane, and (B) ketamine/xylazine 
(100 mg/kg - 10 mg/kg). (C) Group-average blood flow profiles across the retinal thickness under 
isoflurane or ketamine/xylazine from the same animals (n = 7, error bars are standard error of the 




 Table 3.1 summarizes the peak rBF and chBF values under each anesthetic. BF 
under ketamine/xylazine was 42% lower in the choroid (p < 0.01, n = 7) and 29% lower 
in retinal vessels (p < 0.01), compared to isoflurane. The ratio of chBF:rBF was 6.3 under 
isoflurane and 4.8 under ketamine/xylazine, suggesting that these anesthetics affect rBF 
and chBF differently. The magnitude changes of chBF and rBF between anesthetics, -3.4 
and -0.42 ml/g/min respectively, were significantly different from each other (p < 0.05). 
The group average standard deviations across acquisition time for isoflurane were 0.22 
and 0.53 ml/g/min for rBF and chBF, respectively. The group average standard 
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Table 3.1: Blood flow peak values (ml/g/min) of the retinal and choroidal layers under isoflurane 
or ketamine/xylazine (mean ± SD, n=7). Adapted from Muir et al., NMR Biomed 2010, (139) 
a
 p < 0.01 compared to isoflurane, 
b
 p < 0.01 compared to rBF 
 rBF (ml/g/min)  chBF (ml/g/min)  chBF / rBF  
Isoflurane  1.3 ± 0.44  7.7 ± 2.1
b
  6.3 ± 1.9 
Ketamine/Xylazine  0.88 ± 0.22
a
 4.3 ± 1.9
a, b
  4.8 ± 1.2 




Based on the BF profiles, thicknesses of the retinal and choroidal vascular layers 
and the avascular layer in between were estimated (Table 3.2). Average thickness of the 
retina, including the choroid, was about 249 µm under isoflurane and ketamine/xylazine 
(p > 0.05, n = 7). The distances between the rBF and chBF peaks were 170 µm 
(isoflurane) and 161 µm (ketamine/xylazine) (p > 0.05).  
 
 
Table 3.2: Thicknesses (µm) of retinal BF peak, avascular layer, choroidal BF peak, and peak-to-
peak distance between retinal and choroidal vasculatures (mean ± SD, n = 7). Adapted from Muir 










Peak to Peak 
Distance 
Isoflurane 77 ± 24 94 ± 13 78 ± 3 249 ± 19 170 ± 18 




This study demonstrates non-invasive, high-resolution, quantitative blood flow 
measurements of the retinal and choroid vasculature in the mouse retina in vivo. This was 
made possible by the novel cardiac spin labeling BF MRI and a high-performance 
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gradient. Choroidal BF was many times higher than rBF. Additionally, rBF was 29% 
lower while chBF was 42% lower under ketamine/xylazine compared to isoflurane. This 
approach allows quantification of rBF and chBF as well as detecting differences between 
the two anesthetics. MRI ASL BF measurement is: 1) non-invasive which would allow 
longitudinal monitoring of disease progression in vivo, 2) quantitative which facilitates 
comparison across experimental groups, and 3) depth-resolved with high spatial 
resolution which allows unambiguous resolution of rBF and chBF. This novel application 
of BF MRI could serve as a valuable imaging tool to study rBF and chBF regulation in 
normal retinas and perturbations in retinal diseases in a longitudinal fashion. 
Movement and partial-volume effect: In contrast to previous studies of the rat 
retina in which paralytics were found to be needed in addition to isoflurane (9,140), eye 
movement in movies of time-series MRI from isoflurane-anesthetized mice was 
considerably less, so paralytic was not used. Any small motion that did occur over 
prolonged scans was tolerable and effectively corrected by image alignment. While both 
isoflurane and ketamine/xylazine were effective in minimizing eye movement in mice, 
ketamine/xylazine yielded more stable images than isoflurane in the same animals, likely 
because xylazine is also a muscle relaxant (137).  
The in-plane resolution of 42x42 µm2 (before zero filling and interpolation) had 
~6 pixels across the entire retina and choroid. This spatial resolution was sufficient to 
clearly differentiate BF between the retinal and choroidal vascular layers. In the slice 
thickness direction, the partial-volume effect due to the curvature of the retina from a 
slice thickness of 0.4 mm was estimated to be 12 µm or < 5% of total retinal thickness, 
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from a simulation assuming a spherical eye of 3.3 mm diameter and a 270 µm thick retina 
(combined neural retina and choroid). 
Blood flow calculation: The ASL technique for imaging the retina and choroid 
has some assumptions and limitations. The blood-tissue partition coefficient (λ) of the 
brain (64) was used in the BF calculations because the blood-tissue partition coefficient 
in the retina and choroid have not been measured. This is a reasonable assumption for the  
retina because it is neural tissue and has similar BF and water content as gray matter 
(64,66). In this study, the effect of transit time on blood flow measurements was not 
taken into consideration. In rats, transit time to the brain is short, ~200 ms (124), and in 
mice, the transit time is expected to be shorter. Additionally, the labeling efficiency used 
was measured at the brain (114), modeling the transit delay effects as a modulation of 
labeling efficiency.  
However, there could be a slight transit time difference between the two 
anesthetics which may cause some error in BF comparison, although this should likely be 
insignificant in small animals such as mice. In some disease states such as vascular 
occlusive diseases, the effect of transit time could be significant and would need to be 
corrected by using appropriate post-labeling delays. T1 of the retina and choroid have 
been reported to be about 1.8 s at 7 Tesla, similar to brain T1 (68). It has also been 
reported at 11.7 Tesla that retina and choroid T1 are similar to brain T1 (19). BF errors 
from λ and T1 inaccuracies are likely small and cause only a linear scaling. As such, 
reliable comparison across experimental groups can still be made at the least if the 
experimental settings were similar. 
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Thickness measurements from BF data: Images acquired with EPI had relatively 
low resolution compared to the retina and had noticeable geometric distortion which 
likely introduces some error in thickness measurements. Thicknesses derived from the BF 
MRI should still be reasonably close to the ranges measured from histology. The neural 
retina (including rBF layer and avascular layer) determined by BF MRI was about 171 
µm. The neural retina has been reported to be 182 µm in mice (19) and 180 µm in rats (9) 
by anatomical MRI. Histological thickness measurements of the neural retina were 176-
223 µm in mice (19,141,142) and 169 µm in rats (9). Neural retinal thickness in mice and 
rats by MRI and histology are in reasonably good agreement.  
The choroid thickness was 78 µm by BF MRI, consistent with the choroid 
thickness of 86 µm reported in rats (9), although somewhat thicker than 52 µm reported 
in mice (19) with anatomical MRI. Choroid thickness measured by histology is 15-28 µm 
in mice (19,142) and 37 µm in rats (9), thinner than MRI measured thicknesses. Similar 
differences have been noted in humans between in vivo measurements of choroid 
thickness using optical coherence tomography (143) compared to histological 
measurements (144). Possible explanations for this difference include partial-volume 
effect from the limited in-plane MRI spatial resolution, histological shrinkage, and 
collapse of choroid vessels after being removed from the systemic circulation for 
histology. The peak-to-peak distances between the rBF and chBF profiles were 170 and 
161 µm in this study, under isoflurane and ketamine/xylazine, respectively, comparable 
to the peak-to-peak distance of 162 µm in rats measured by anatomical MRI (9). 
Quantitative rBF and chBF: Under isoflurane, rBF was 1.3 ml/g/min and chBF 
was 7.7 ml/g/min. Under ketamine/xylazine, rBF was 0.88 ml/g/min and chBF was 4.3 
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ml/g/min. Retinal BF and chBF have been reported using destructive techniques 
including microspheres, autoradiography, krypton-85 washout, and hydrogen clearance 
methods. Table 3.3 summarizes the results from these methods in various species and 
experimental conditions. Values of rBF are seen to range from 0.12-3.73 ml/g/min while 
chBF ranges from 2-18.98 ml/g/min. The MRI BF measurements fall somewhere in the 
middle of these reported ranges. 
 
 
Table 3.3: Reported values of retinal, choroidal, and cerebral blood flow (rBF, chBF, and CBF 
respectively) in ml/g/min, except where noted. Adapted from Muir et al., NMR Biomed 2010, 
(139) 
Ref Method Animal Anesthesia rBF chBF CBF 
(22) microspheres monkey  0.48 18.98 0.78 
(35) microspheres cat urethane 0.198   
(7)
a
 microspheres cat a-chloralose 0.141 7.46  
(25) microspheres cat halothane 0.54 13.09 0.69 
(26) microspheres rat Inactin 0.44 1.42
b
 0.58 
(145) microspheres rat thiopental 0.4 3.8
b
 0.58 





(146) microspheres dog pentobarbital 0.12 9.61  
(147) microspheres dog pentobarbital/succinylcholine 0.91   
(28) autoradiography rat awake 0.92  0.97 
(148) krypton-85 cat pentobarbital 1.66 12  
(95) H2 clearance rat Inactin 3.73   
(92) H2 clearance cat a-chloralose 0.56   
(91) H2 clearance dog pentobarbital/thiopental   2-4   
a
Values reported as g/g/min. Given that blood density is 1.06 g/ml (64), values in g/g/min and 
ml/g/min units are essentially equal. 
b
Values are of the combined choroid and sclera, likely reducing the quantitative value 
substantially. 
c




These comparisons show that rBF and chBF measurements vary over a wide 
range. Factors that could contribute to this spread include differences in species, 
anesthetics, and methodologies. The extent of the retinal vasculature varies widely in 
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mammals, with some species even completely lacking this vascular layer (149,150), 
giving rise to large species difference. As demonstrated different anesthetics and dosages 
have marked effects on BF (151). MRI BF measurements have some assumptions as 
described above. The size and dose of microspheres can also have significant effects on 
measurement of rBF and chBF (90). BF in the eye measured by microspheres is often 
given in units of µl blood/min/whole tissue. Conversion to ml/g/min requires the weight 
of whole neural retina and whole choroid. Such conversion could introduce inaccuracies 
in quantitative values through dehydration of tissue before weighing, difficulty separating 
the whole retina and choroid from other tissues, and use of the entire retina weight when 
the retinal vessels only perfuse the inner retina (7,35).  
Regardless of experimental conditions or units, chBF has been consistently 
reported to be many times higher than rBF (7,22,35,148,152), with the chBF:rBF ratios 
ranging from 7 (148) to 80 (146). In this study, MRI measured chBF to be 6.3 times 
larger than rBF under isoflurane and 4.8 times larger under ketamine/xylazine, most 
consistent with findings using the krypton-85 washout method (148). High chBF also 
agrees with a previous MRI study which reported combined rBF and chBF in rats at a 
resolution that was insufficient to resolve the retinal and choroid vascular layers as 6.3 ± 
1.0 ml/g/min under 1% isoflurane and similar experimental conditions to those used 
herein (151).  
Table 3.3 also summarizes CBF data measured in the same animals as rBF and 
chBF. By comparison, chBF is many time higher than CBF, whereas rBF is similar to 
CBF. CBF has been reported to be 0.86-1.27 ml/g/min in rats (128) and 1.1 ml/g/min in 
mice (see Chapter 2) (114) under 1% isoflurane, similar to rBF (1.3 ml/g/min) but much 
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lower than chBF (7.7 ml/g/min) measured herein. Together, these comparisons support 
the validity of MRI ASL BF measurements in the retina and choroid. 
Effects of different anesthetics: Isoflurane is a known vasodilator. BF under 
isoflurane is higher than awake conditions in the brain (128,136), and higher isoflurane 
concentration yields higher CBF up to 2% isoflurane (128,136). In the rat retina, total BF 
(combined rBF and chBF) under 1.5% isoflurane was 48% higher compared to 1.0% 
isoflurane (151), showing similar effects as in the brain. However, in the cat eye, 
halothane caused rBF to increase while chBF decreased (25). In contrast, 
ketamine/xylazine is known to cause vasoconstriction and has been shown to yield 25-
65% lower CBF compared to isoflurane, depending on brain region (138).  
Both rBF and chBF were higher under isoflurane compared to ketamine/xylazine, 
consistent with the anesthetic effects in the brain. This is likely the combined effects of 
the removal of vasodilatory isoflurane and the addition vasoconstrictive ketamine/ 
xylazine. Choroidal BF under ketamine/xylazine was 42% lower, but rBF under 
ketamine/xylazine was only 29% lower compared to isoflurane. These changes could be 
due to systemic effects of the anesthetics or local effects, which could explain the large 
BF difference in the choroid.  
Systemic respiratory, cardiovascular, or metabolic differences between the two 
anesthetics could account for these global BF differences. The respiration rate was lower 
under ketamine/xylazine compared to isoflurane, which could potentially result in lower 
partial pressure of arterial oxygen (PaO2) and higher partial pressure of arterial carbon 
dioxide (PaCO2) (137,138). These changes could not explain the lower BF under 
ketamine/xylazine because they should increase BF. Ketamine/xylazine does not have 
 43
significant effect on blood pressure relative to isoflurane in rats (138), but xylazine has 
been reported to cause an initial hypertension followed by a return to normal or low 
blood pressure (137).  
Xylazine could affect rBF and chBF differently. Xylazine is an α2-agonist which 
binds central and peripheral α2-adrenoreceptors in the sympathetic nervous system. 
(137). The choroid contains sympathetic nerves which can induce vasoconstriction 
(43,44,153) while retinal vessels lack direct sympathetic innervation (44,153). This could 
explain why ketamine/xylazine reduced chBF more than rBF. 
3.2 Layer-Specific Blood Flow Functional MRI with Hypoxic Challenge 
3.2.1 Methods 
Animal preparation: Experiments were performed on C57BL/6 mice (female, 17-
25 g, n = 7). Mice were imaged under 1.2% isoflurane and spontaneous breathing 
conditions. Animals were placed in an animal holder with ear and tooth bars. Respiration 
rate and rectal temperature (37 ± 0.5
o 
C) were monitored and maintained within normal 
physiological ranges. Baseline conditions consisted of 30% O2 in balance nitrogen. Mice 
were prepared in a lit room before being transferred to the MRI room, in which lights 
were turned off. Lighting conditions were not changed during the duration of imaging.  
Hypoxic challenge used premixed gas of 10% O2 and balance N2. The baseline 
consisted of 30% O2 with balance N2. Each trial consisted of a 9 min scan with baseline 
conditions during the first 4.5 min of the trial and hypoxia during the second 4.5 min. A 
10 min break was given between trials for the animals to return to normal physiologic 
conditions. Two repeated measurements were typically made. 
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MRI methods: MRI studies were performed on a 7 Tesla, 30 cm horizontal 
magnet and a 100 G/cm BGA6S gradient insert (Bruker, Billerica, Massachusetts). For 
imaging, a small circular surface eye coil with active decoupling (diameter = 6 mm) was 
placed over the left eye. A circular labeling coil (diameter = 8 mm) was placed at the 
heart position for a cardiac ASL technique (114). The two coils were separated by about 
2.3 cm from center to center.  
BF MRI was acquired using two-coil continuous ASL with an inversion-recovery, 
echo planar imaging (EPI) sequence. Paired images, one with and one without labeling, 
were acquired in an interleaved fashion. ASL employed a 2.1 s square radio frequency 
pulse to the labeling coil in the presence of 2.0 G/cm gradient along the flow direction 
with a post label delay of 10 ms. The sign of the frequency offset was switched for non-
labeled images. MRI was acquired with inversion-recovery to suppress the strong 
vitreous signal and reduce noise and motion artifacts in BF images. The inversion pulse 
was an adiabatic 20 ms hyperbolic secant pulse, occurring prior to the application of the 
labeling pulse.  
Images were acquired in a coronal orientation with a single slice passing through 
the retina at the optic nerve head, with the slice angled perpendicular to the retina. 
Inversion-recovery, gradient-echo EPI was used with field of view = 6.0x6.0 mm
2
. Basal 
BF images (n = 7) were acquire with 2 segments, matrix = 144x144 (42x42 µm2), a 
single 0.4 mm slice, TR = 4.0 s, TE = 11.7 ms, and inversion time = 2.12 s. fMRI of 
hypoxia (n = 7) was acquired with a single segment, matrix = 128x128 or 112x112 
(47x47 µm2 or 54x54 µm2), a single 0.6 mm slice, TR = 4.0 s, TE = 12.7 or 14.9 ms, and 
inversion time = 2.12 s. For quantitative calculation of BF, regular gradient-echo EPI 
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scans (without inversion recovery) were also acquired. The imaging parameters were 
otherwise the same, except for TR = 3.0 s. 
Data analysis: Image analysis was done using codes written in Matlab (Math-
Works, Natick, MA), STIMULATE software (University of Minnesota), and Statistical 
Parametric Mapping 5 (SPM5) software. Images were zero-padded to 256x256 for basal 
BF imaging or 128x128 for fMRI imaging before Fourier transform into imaging space. 
All images from each scan were acquired as time series, aligned using the spatial 
realignment function in SPM5 and averaged off line.  
Blood flow images of the eye, in units of ml/g/min, were calculated pixel-by-pixel 
using Eq. 3.1. M0 is the equilibrium value of the magnetization of the object, which was 
approximated as the gradient-echo EPI images without inversion recovery. λ, the water 
tissue-blood partition coefficient, was taken to be 0.9, the same as the brain (64). The 
retina and choroid T1 at 7 T was taken to be 1.8 s (68) which is similar to brain T1. A 
value of 0.7 was used for α, the labeling efficiency, as was previously measured in the 
distal internal carotid arteries at the base of the frontal lobe (114). The labeling duration, 















   (Eq. 3.1) 
 
Profile analysis was used to calculate basal BF values, BOLD %-changes, and 
magnitude and BF %-changes. Anatomy and BF intensity profiles across the retinal 
thickness were obtained from the images by radially projecting lines perpendicular to the 
retina (9,139) with profiles obtained at 8x spatial interpolation. Further motion correction 
was performed on the extracted profiles in Matlab (see Chapter 4.2 for details). The 
inversion-recovery and regular EPI images were aligned separately, and then the 
 46
averaged anatomical profiles from both scans were both manually aligned before BF 
calculation.   
Percent-change BOLD profiles were calculated from the anatomical profiles of 
the non-labeled images and averaged across the length of the retina. The BOLD %-
change was then measured as the peaks of the averaged BOLD profile located at the 
choroidal and retinal vasculatures. BF profiles were calculated using Eq. 3.1 and 
averaged along the length of the retina. BF values were obtained under baseline and 
hypoxic conditions separately, and then magnitude and percent BF changes were 
calculated from these values. Reported values come from the peak values of the profiles. 
3.2.2 Results 
Figure 3.4 shows a basal BF image at 42x42x400 µm3 from a single animal and 
the group-averaged basal BF profile across the retina. Retinal and choroidal BF and the 
avascular layer in between were well resolved. Basal chBF at 42x42x400 µm3 was 7.1 ± 
1.4 ml/g/min, and rBF was 1.2 ± 0.24 ml/g/min (mean ± SD, n = 7). Basal chBF was 5.9 
times higher than rBF. The BF images and quantitative values are similar to those 
previously found and reported in Section 3.1, in which inversion-recovery background 
suppression was not used. 
Figure 3.5 shows BF and BOLD % change maps associated with hypoxia from a 
single animal. Hypoxia decreased BF and BOLD signals, with distinct responses in the 
retinal and choroid layer. Figure 3.6 shows profiles from the hypoxia fMRI, including BF 
under 30% and 10% O2, the BF magnitude change, and the BOLD % change. Distinct 
layers corresponding to the retinal and choroidal vascular layers could be distinguished in 
the BF and BOLD fMRI profiles. Group-averaged data are summarized in Table 3.4. In 
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magnitude, the decrease in chBF was 5.2 times more than rBF, but BF % changes were 






































Figure 3.4: (A) Blood flow image from a mouse at 42x42x400 µm3. (B) Group-average blood 































Figure 3.5: (A) BF and (B) BOLD % change maps due to hypoxia overlaid on the EPI image 
























































































Figure 3.6: Profiles of BF and BOLD changes from one mouse. (A) BF profiles under 30% and 
10% O2. (B) BF magnitude-change profile calculated from the subtraction of the BF profile under 
10% O2 from the BF profile under 30% O2. (C) BOLD %-change profile. The vertical black lines 




Table 3.4: Layer-specific basal BF and BF and BOLD responses to hypoxia (mean ± SD, n = 7) 
*p < 0.01 compared to choroidal layer, 
†
p < 0.01 compared to BF under 30% O2 
Vascular 
Layer 
Blood Flow BOLD 
Percent 
Change (%) 












Retinal 1.2 ± 0.32* 0.62 ± 0.22*† -0.58 ± 0.31* -47 ± 16 -15 ± 4.0* 




ASL MRI was able to detect layer-specific changes of BF and BOLD signals in 
the retina and choroid during hypoxic challenge. The BOLD signal was found to drop in 
the retina and choroid, as would be expected from hypoxia. BF of the retina and choroid 
was found to drop in response to hypoxia, opposed to an increase in BF as might be 
expected. Similar decreases in BF of the brain have also been reported (52,154). Two 
likely reasons for the decrease in BF are drops in mean arterial blood pressure and PaCO2 
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which are generally found in acute hypoxic challenge. In rats (52) and mice (155,156), 
blood pressure has been reported to drop during hypoxia, which could cause decreased 
BF. In free breathing animals, hypoxia tends to cause increased respiration rate, which 
will cause hypocapnia, which is vasoconstrictive (154). 
The magnitude decrease of chBF was significantly larger than rBF, but the 
percent decrease of chBF and rBF were almost the same due to the high basal chBF. The 
rBF responses to hypoxia were similar to the brain, in both magnitude and % changes. 
Hypoxia is reported to reduce CBF by 48% under similar conditions (154). The chBF 
magnitude change due to hypoxia was larger than that reported for CBF, while the % 
change of chBF and CBF were similar (154). These findings caution interpretation of BF 
fMRI %-changes in diseased states where basal BF is significantly altered.  
If the changes in BF are actually in part due to hyperventilation-induced 
hypocapnia, then this offers an explanation for the large change in BF in the choroid. The 
retinal circulation is responsive to modulations of O2 and CO2, while the choroid has little 
response to O2 but is responsive to CO2 (33,157). This could potentially lead to large 
chBF decreases in response to hypoxia induced hypocapnia since there is no regulatory 
response to the low O2, as in retinal or cerebral circulations. Additionally, the retinal and 
choroidal circulations may have differences in their autoregulation to changes in 
perfusion pressure to maintain BF. rBF is consistently reported to be autoregulated (38), 
while chBF is reported to have (41) and to lack (40) autoregulation. Thus, it is uncertain 
what affect a drop on blood pressure would have on the two vasculatures, but it might be 
that chBF has less autoregulatory ability and would then have a larger change in BF due 
to a drop in blood pressure.   
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The hypoxia-induced BOLD decrease was larger in the choroid compared to the 
retinal vascular layer. In the brain, hypoxia is reported to reduce BOLD by 9% (154), 
similar to the retinal response and lower than the choroidal response. The large choroid 
BOLD change compared to the retinal layer and the brain could be a result of high basal 
blood volume and vascular density of the choroid (23,158) or the large magnitude chBF 
decrease that occurred. 
These findings demonstrated differential responses to hypoxia between the retinal 
and choroidal vasculatures. This is consistent with a previous MRI study which showed 
layer-specific BOLD responses to hyperoxia and hypercapnia in the rat retina at 
90x90x1000 µm3 (9). This is also consistent with laser Doppler flowmetry studies of 
hyperoxia and hypercapnia in the optic nerve head where retinal vessels dominate and in 
the fovea where retinal vessels are absent (159). A previous MRI study in rats reported 
BF changes of the retina in response to hyperoxia and hypercapnia, but at a resolution 
insufficient to resolve the retinal and choroidal vasculature (100).  
3.3 Conclusions 
It was demonstrated that MRI could be used to image layer-specific blood flow to 
the retina and choroid for the first time, providing both basal BF and functional BF 
changes. Quantitative retinal and choroid BF could be clearly resolved in vivo by high-
resolution MRI. The BF MRI approach was capable of detecting the effects of isoflurane 
and ketamine/xylazine anesthesia on rBF and chBF. Additionally, the feasibility of layer-
specific BF fMRI was demonstrated using hypoxic challenge. MRI has the potential to 
provide information on the unique rBF and chBF regulation in the normal retina, and rBF 
and chBF dysregulation in disease states. Quantitative blood flow measurement affords 
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comparison of BF changes between experimental groups, facilitating early detection and 
monitoring of treatment efficacy. The BF fMRI technique could provide a means of 




PASSBAND BALANCED STEADY STATE FREE PRECESSION 
FUNCTIONAL MRI OF THE RETINA 
 
MRI can non-invasively image functional hemodynamic responses without depth 
limitation. Blood oxygen level dependent (BOLD) fMRI, based on the susceptibility 
effects of hemoglobin in blood, is the most commonly used MRI technique to study 
function (160). Most BOLD fMRI studies prefer echo planar imaging (EPI) over 
conventional gradient-echo or spin-echo sequences because EPI allows rapid, real-time 
image acquisition. However, EPI is vulnerable to susceptibility artifacts such as 
geometric distortion and signal dropout due to magnetic inhomogeneity. Standard 
gradient echo sequences have been used for BOLD fMRI, but are much slower than EPI 
and have lower SNR per unit time, making them impractical for retinal imaging. 
MRI of the retina is particularly prone to these artifacts because the region around 
the eye is very inhomogeneous and is at an air-tissue interface. A few functional MRI 
studies of the retina have been previously reported. BOLD fMRI of the retina using EPI 
has detected changes associated with physiologic stimulations (9) and visual stimulation 
(98,99). Perturbations of BOLD fMRI to physiological challenges in rat retinas with 
retinal degeneration have also been reported (9).  
Balanced steady state free precession (bSSFP) sequences provide fast acquisition, 
in contrast to conventional MRI sequences, have high SNR, and do not have geometric 
distortion or signal dropout artifacts associated with EPI. The bSSFP signal is, however, a 
highly sensitive function to off-resonance frequency shifts, producing passbands and 
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transition bands (Figure 4.1) (161,162). The passband has high signal while the transition 
band has low signal (except at small flip angles where this contrast is reversed) (162). 
Magnetic inhomogeneity across an object will result in dark bands in some regions of 
images obtained with bSSFP. The passbands and transition bands in an image can be 





Figure 4.1: Simulation of the magnitude of the bSSFP signal as a function of resonance phase 
offset during TR. Parameters of the simulation include T1 = 2.0 s, T2 = 43 ms, flip angle = 30
o
, 








bSSFP fMRI was only recently demonstrated, initially making use of the 
transition bands where the signal is very sensitive to off-resonance frequency shifts, such 
as those caused by deoxyhemoglobin (163,164). Passband bSSFP fMRI was later 
demonstrated as well, in which imaging is done within the wider and more stable 
passband region (161,165). Passband bSSFP fMRI has been shown to be useful in human 
brain imaging, particularly in regions of large magnetic susceptibility such as the 
prefrontal cortex where EPI has severe artifacts (166). 
 54
The features of bSSFP make it an attractive sequence for fMRI of the retina. In 
this study, the feasibility of high spatiotemporal resolution, passband bSSFP fMRI to 
resolve layer-specific changes in the mouse retina and choroid was explored. As a 
demonstration of proof of concept, hypoxic challenge was used to modulate BOLD 
signals. bSSFP fMRI of the eye at 45x45x500 µm3 was free of susceptibility related 
artifacts and provided high-resolution, layer-specific images sensitive to blood 
oxygenation changes. This approach provides high spatiotemporal resolution without 
susceptibility artifacts for functional of imaging the retina and choroid.  
4.1 Methods 
Animal preparation: Experiments were performed on male C57BL/6 mice (8-16 
weeks old, n = 6). Animals were placed in a holder with a circulating warm water pad 
and nose cone to provide anesthesia and premixed gases. Imaging was performed under 
1.1% isoflurane and spontaneous breathing conditions. Mice were provided 30% O2 in 
nitrogen as baseline conditions. Hypoxic challenge was performed by switching the 
provided gas mixture to 10% O2 in nitrogen. Respiration rate, heart rate, oxygen 
saturation, and rectal temperature were monitored. Temperature was maintained at 37 ± 
0.5° C. Mice were prepared in a lit room before being transferred to the MRI room, in 
which lights were turned off. Lighting conditions were not changed during the duration of 
imaging. 
MRI methods: MRI studies were performed on a 7 Tesla, 30 cm magnet and a 150 
G/cm BGA6S gradient insert (Bruker, Billerica, MA). For imaging, a small circular 
surface eye coil (diameter = 6 mm) was placed over the left eye. Images were acquired 
using bSSFP in a coronal orientation with a single slice passing through the retina near 
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the optic nerve head, with the slice angled perpendicular to the retina. Imaging 
parameters were field of view = 5x5 mm
2
, matrix = 112x112 (45x45 µm2), one 0.5 mm 
thick slice, and 3.67/7.34 ms TE/TR. Data were oversampled by 2x in both frequency and 
phase encode directions.  
FASTMAP shimming was used to reduce banding, and the RF phase cycling was 
adjusted to move bands away from the retina. Alternatively, bSSFP images were acquired 
with 4 alternating RF phase cycling angles (0, 90, 180, and 270
o
) and combined to 
remove banding from the image (n = 1). Hypoxic challenge involved imaging 4.5 min 
during baseline and 4.5 min during hypoxia. Hypoxic challenge was repeated twice in all 
animals with 10 min rests between trials. 
Gradient-echo EPI images under 30% O2 were obtained with the same slice 
position and resolution for comparison to bSSFP images. Parameters for EPI images were 
field of view = 6x6 mm
2
, matrix = 134x134 (45x45 µm2), one 0.5 mm slice, BW = 333 
kHz, either 1 or 2 segments, and TE/TR = 12.0/2000 ms. 
Data analysis: Image processing and analysis was done using codes written in 
Matlab (Math-Works, Natick, MA), STIMULATE software (University of Minnesota), 
and Statistical Parametric Mapping (SPM5) software. Images were zero-padded to 
128x128 (nominal resolution of 39x39 µm2) before subsequent processing. All images 
from each scan were acquired as time series and aligned using the spatial realignment 
function in SPM5. bSSFP images acquired with 4 phase cycling angles were combined 
by averaging 3 of the 4 highest image intensities pixel-by-pixel before motion correction. 
Image intensity profiles across the retinal thickness were obtained from the 
anatomical images by radially projecting lines perpendicular to the retina (Figure 4.2 A) 
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with profiles obtained at 8x spatial interpolation (9). Percent-change between baseline 
and hypoxia was calculated for each profile, and all profiles were averaged along the 
length of the retina to provide an average %-change profile for the retina. Peak %-change 
values were determined from the average %-change profile for each animal. 
STIMULATE was used for display and calculation of %-change maps of the final 
motion-corrected images. For the %-change maps, a 95 or 99% confidence interval was 
used with a %-change threshold between about -5% to -100% and a cluster size of at least 
20 contiguous pixels. The %-change map was masked to remove signal decreases in 
extra-ocular tissues and strong fluctuations in the anterior portion of the eye around the 
transition bands.  
Group-average data were tabulated and expressed as mean ± SD. Statistical 
analysis with either one-sample t-tests comparing to zero mean or paired t-tests were 
used, with p < 0.05 indicating statistical significance. 
4.2 Profile Realignment and Motion Correction 
Movement of the eye due to the animal is often non-uniform across the eye and 
the retina. Thus, global rigid-body motion correction of the entire image of the eye cannot 
optimally correct motion in all parts of the eye. Further, motion of anterior parts of the 
eye and extra-ocular tissue can occur separately of the motion that occurs in the retina. 
Since only the retina is of interest, motion correction performed on the extracted, 
linearized retina should work better than global correction of the entire eye. As such, the 
motion correction done by SPM5, which corrected for translation and rotation, effectively 
removed any large motion, but smaller subtle motion of the retina could remain 
uncorrected.  
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After obtaining profiles across the retina from the anatomical images (Figure 4.2 
A), further motion correction was performed on the extracted profiles in Matlab. This 
was done by correcting for 1 dimensional translation in the direction perpendicular to the 
retina (Figure 4.2 B-C). This realignment was first done on the entire group of profiles 
together. This was followed by realignment applied to smaller blocks of profiles (usually 
blocks of 5-10 profiles) to correct for non-uniform movement across the retina which 
occurred during some experiments. After profile realignment, the motion-corrected 
anatomical profiles were projected back into the anatomical images (Figure 4.2 D-E) for 






Figure 4.2: (A) bSSFP image showing radially projected profiles (blue lines) perpendicular to the 
inner edge of the retina (green line). The white arrows indicate the region selected for profile 
analysis. (B) The linearized retina from the collection of profiles shown in A. (C) The linearzied 
retina after motion correction applied to the profiles. (D) The original image with blurring due to 
motion. (E) The image after projecting the motion corrected profiles back into the original image. 




In isoflurane anesthetized mice, the motion of the eye most commonly occurring 
in the MR images was a small jittering or a slow drift of the eye oriented in and out of the 
eye socket. This type of motion could be corrected very effectively with the profile 
realignment. Although it rarely occurred, rotation of the eye within the socket, either 
 58
through-plane or within-plane, would not be effectively corrected by this profile 
realignment. Finally, severe motion, including large twitches or deformations of the eye, 
which is also quite rare, would be unlikely to be accurately corrected through any means.  
4.3 Results 
Physiological parameters of the mice under 30% and 10% O2 are summarized in 
Table 4.1. Respiration rate and heart rate were significantly increased under 10% O2 
compared to 30% O2, while arterial O2 saturation was significantly lower.  
 
 
Table 4.1: Physiological parameters of mice under 30% and 10% O2 (mean ± SD, n = 6) 








30% O2 91 ± 11 371 ± 29 97 ± 1 




EPI and bSSFP images of the same eye at 45x45x500 µm3 are shown in Figure 
4.3. The EPI images (Figure 4.3 A, 1 segment; Figure 4.3 B, 2 segments) show distortion 
in the retina as well as the rest of the eye. One to three distinguishable retinal layers were 
usually detected in EPI with non-uniform structure and thickness along the retina. In 
contrast, bSSFP (Figure 4.3 C) produced images without obvious distortion. Four 
distinguishable dark-bright-dark-bright retinal and choroidal layers were detected in the 







Figure 4.3: EPI images at 45x45x500 µm3, demonstrating the geometric distortion and other 
artifacts in the eye acquired with (A) 1 segment or (B) 2 segments. Phase encoding orientation is 
left-right. (C) bSSFP image (45x45x500 µm3) from the same animal acquired during baseline 




Figure 4.4 A shows a representative %-change map associated with hypoxic 
challenge from a single mouse using bSSFP. Hypoxia decreased the signal in the retina, 
with a stronger response in the choroidal vascular layer than the retinal vascular layer. 
Anatomy profiles during baseline and hypoxia (Figure 4.4 B) show four alternating dark-
bright-dark-bright layers. Figure 4.4 C shows the corresponding %-change profile due to 
hypoxia. Two well resolved layers were detected in the %-change maps and profiles that 
showed signal reductions. These layers were assigned to be the retinal and the choroidal 
vascular layer. The middle layer in between these two vascular layers showed no 
significant change and was assigned as the avascular photoreceptor layers (outer nuclear 
layer and inner and outer segments).  
The group-averaged %-changes were -11.6 ± 2.4 % in the inner (retinal) layer (p 
< 1E-4), -1.6 ± 1.4 % in the middle (avascular) layer (p < 0.05), and -25.9 ± 6.4 % in the 
outer (choroid) layer (p < 1E-3) (mean ± SD, n = 6, one-sample t-test comparing the 
sample mean to zero). The %-changes in the middle layer were statistically different from 
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that of the inner (p < 1E-3) and outer layer (p < 1E-3) (paired t-test). The %-changes of 



























































Figure 4.4: (A) Percent-change map in response to hypoxia from a single mouse at 45x45x500 
µm3 overlaid on the bSSFP image. The bSSFP images during (B) baseline and (C) hypoxia. (D) 
The corresponding anatomical profiles (arbitrary units) of the retina during baseline and hypoxia. 
(E) The %-change profile due to hypoxia. The red dashed lines indicate the location of peak 




A potentially major problem with bSSFP is banding artifacts. The transition bands 
can be moved away from the region of interest with RF phase cycling. Alternatively, 
images obtained using multiple RF phase cycling angles can be combined to remove 
banding artifacts. Figure 4.5 demonstrates that images acquired with 4 RF phase cycling 
angles can be used to effectively remove all dark transition bands from the bSSFP image 
of the eye, while maintaining sensitivity to functional changes. 
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Figure 4.5: (A-D) bSSFP images of the eye with RF phase cycling of 0, 90, 180, and 270
o
. (E) 
The four images are combined by averaging the 3 of the 4 highest intensities pixel-by-pixel to 
remove banding. (F) The %-change map in response to hypoxia overlaid on the bSSFP image 
with banding removed. 
 
4.4 Discussion 
 This study demonstrates for the first time the feasibility of applying passband 
bSSFP fMRI to the retina without magnetic susceptibility-induced signal drop out and 
geometric distortion. In the bSSFP images of the eye, the retina had clearly defined 
structure and layers, unlike EPI, allowing for clear definition of both functional and 
anatomical layers of the retina and choroid. The temporal resolution and SNR per unit 
time of bSSFP should be comparable to EPI. 
Movement: From movies of MRI time-series images, eye movement in isoflurane-
anesthetized mice was considerably less than in rats, so paralytics were not used (9,139). 
The profile realignment discussed in Section 4.2 was effective at correcting small 
movements which still occurred in some scans. The use of paralytics would likely 
provide almost no motion and thus better image results, particularly for fMRI. However, 
successfully recovering rats and mice from paralysis and mechanical ventilation is 
difficult, so most studies with paralytics are terminal. Additionally, paralytics and 
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anesthesia generally could not be used in human studies, so effective means of correcting 
motion of the retina is essential.  
fMRI of the retina: The eye is an area with large magnetic field inhomogeneity, 
which results in substantial artifacts in EPI images. bSSFP images were free from these 
artifacts, although the banding present in bSSFP MRI could be problematic. Banding 
occurs mostly in regions with large magnetic inhomogeneity, like signal drop out and 
image distortion artifacts in EPI, so bSSFP imaging of the eye could be prone to severe 
banding. With FASTMAP shimming using first-order gradients with a small voxel placed 
within the eye and adjustment of RF phase cycling angle in each animal, the banding 
could consistently be moved away from the retina. Additionally, strong imaging gradients 
are necessary to allow for rapid acquisition (short TR to minimize banding) while 
maintaining the small FOV needed for high-resolution, laminar imaging of the retina. 
Meanwhile, geometric distortion and other artifacts were still present in EPI even with 
FASTMAP shimming and the strong gradients to minimize readout time. If the banding 
did pose a problem in the bSSFP images, they could be removed by acquiring and 
combining images with multiple RF phase cycling angles, although this will decrease 
temporal resolution and SNR. 
Passband bSSFP fMRI of the retina during hypoxia showed negative signal 
changes, as would be expected of BOLD fMRI. Passband bSSFP fMRI yields contrast 
similar to T2 or T2* BOLD (167), but the sources of the bSSFP fMRI signals have been 
unclear, with dependence on TR/TE and field strength (161,162,166,167). Nonetheless, 
the bSSFP parameters that were used showed good sensitivity to oxygenation changes. 
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A previous MRI study using EPI demonstrated layer-specific BOLD responses to 
hyperoxia and hypercapnia in the rat retina at lower resolutions, 90x90x1000 µm3 (9). 
The BOLD study demonstrated differential response between the inner and outer edges of 
the retina, likely corresponding to the retinal and choroid vessels, although the retina 
consisted of only a single anatomical layer. By comparison, layer-specific bSSFP fMRI 
was obtained at much higher resolution and with 3 clearly separated functional layers, 
overlaid on 4 anatomical layers. 
Response of the retina to hypoxia: The signal decrease due to hypoxia was 
significantly larger in the choroid (-25.9 ± 6.4 %) than retinal vascular layer (-11.6 ± 2.4 
%). One factor contributing to this difference is likely the high basal choroid blood 
volume compared to the inner retina (23,149,158), since the BOLD response increases 
with higher basal blood volumes (160,168). Additionally, the choroid vessels have 
extremely low oxygen extraction fraction compared to the retinal vessels (23,169) which 
could potentially factor into different BOLD responses between the two layers. It is 
difficult to predict what effect, if any this would have though, without knowing the 
oxygen saturation of both vasculatures under normoxic and hypoxic conditions. Finally, 
as previously described in Chapter 3, under the same experimental conditions and 
hypoxic challenge, blood flow of the retina and choroid both decrease, with a much larger 
change in magnitude in the choroid. This could perhaps result in a larger increase in 
deoxyhemoglobin concentration in the choroid. Although the small response of the outer 
retina (-1.6 ± 1.4 %) was significant at p = 0.04, this change is possibly due to partial 
volume from the inner retina and choroid due to the relatively low in-plane resolution.  
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Four alternating dark-bright-dark-bright anatomical layers were present in the 
bSSFP images. The lamina-specific bSSFP fMRI response could thus be assigned to 
specific MRI anatomical layers with bSSFP, unlike EPI which lacked clear anatomical 
layers. The %-change peak of the choroid consistently lined up with the outermost bright 
layer of the anatomy. The %-change peak of the retinal layer appeared to span the inner 
dark and bright layer of the anatomy. The dark layer in the middle of the retina is 
therefore likely the photoreceptors (outer nuclear layer and inner and outer segments), 
although further work is needed to assign the MRI layers to specific anatomical layers. 
A previous BOLD fMRI study using hyperoxia in rats found a stronger signal 
increase in the choroid than inner retina (1.7 time larger), similar to the hypoxic changes 
with bSSFP (9). This further supports the interpretation that high choroidal blood volume 
is an important factor in the BOLD response, since venous choroidal oxygen saturation is 
similar to arterial blood (23,169). Hyperoxia should therefore only have small changes on 
the concentration of deoxyhemoglobin in the choroid, but with such large volumes of 
blood in the choroid, this could still have a large change in the total quantity of 
deoxyhemoglobin in the choroid. 
4.5 Conclusions 
Functional MRI of the retina is challenging because the eye is a region with large 
magnetic inhomogeneity, causing substantial artifacts in EPI sequences usually used for 
fMRI studies. Passband bSSFP fMRI of the retina yields high spatial and temporal 
resolution without geometric distortion and signal dropout. Differential responses of the 
retinal and choroidal vasculature, separated by the avascular region of the outer retina, 
were detected. This MRI approach is sensitive to blood-oxygenation changes. bSSFP 
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fMRI has the potential to provide layer-specific information about vascular regulation in 
the normal retina and dysregulation in disease states. 
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CHAPTER 5 
BLOOD FLOW OF THE RETINA IN DIABETIC RETINOPATHY 
 
Diabetic retinopathy (DR) is the leading cause of blindness in most developed 
countries (170,171). Approximately 40% of adult diabetic patients in the United States 
have DR (172) and the prevalence rises to 75% among patients with type 1 diabetes 
(173). Dysfunction of the retinal vasculature is the most prominent feature of diabetic 
retinopathy, signs of which are used clinically to diagnosis the disease. Vascular changes 
include thickening of the vascular layers, altered vascular autoregulation, capillary non-
perfusion, plasma protein leakage, ischemia, and ultimately proliferative growth of new 
vessels (174-176). The changes in retinal and choroidal blood flow in diabetic 
retinopathy are complex and remain unclear, with conflicting reports finding no changes 
in blood flow in diabetics (2,177), increased blood flow (3,178,179), and decreased blood 
flow (4).  
Since high-resolution ASL MRI had been demonstrated to be capable of imaging 
quantitative blood flow of the retina and choroid, this technique was applied to a mouse 
model of diabetes. ASL MRI was utilized to image quantitative, layer-specific retinal 
blood flow (rBF) and choroidal blood flow (chBF) in the Ins2
Akita
 (Akita) mouse model 
of diabetic retinopathy. Additionally, visual function was assessed in the mice using 





5.1 Diabetic Retinopathy 
Hyperglycemia and possibly other risk factors associated with diabetes, such as 
hypertension, induce various physiological changes which can damage the 
microvasculature (180). Factors involved in this damage include oxidative stress, 
inflammation, and increased advanced glycation end-products, which result in ischemia 
and hypoxia, increased permeability of vessels, and microaneurysms (180,181). This can 
eventually lead to neovascularization and macular edema resulting in severely impaired 
vision (180,181). Diabetes may also directly affect the retinal neurons in addition to the 
retinal vasculature, causing damage to the retina preceding clinical diagnosis (182). 
Possible mechanisms for neuronal damage could be directly related to hyperglycemia or 
reduced activity of retinal insulin receptors (182,183). 
The most commonly studied animal models of DR have diabetes induced using 
toxins such as streptozotocin (STZ) or alloxan to kill pancreatic β-cells, causing 
hypoinsulemia and hyperglycemia (184,185). Although STZ rats are a common model, 
the use of STZ in mice can be problematic, due to large strain-dependent variations in the 
effectiveness of STZ (185). There are a number of genetic models of type 1 and type 2 
diabetes in mice (186-188) and rats (189,190) that provide an alternative to the toxin 
induced diabetes. 
While it is important to monitor progressive visual deficits that occur in human 
patients with diabetes, visual testing has not been commonly reported in animal models 
of DR, aside from electroretinograms (ERG). In diabetic patients, visual deficits in 
contrast sensitivity, visual acuity, color vision, and ERG precede the clinical signs of 
vascular lesions (191-195). Visual function assessed by ERG in animal models indicates 
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disruptions in the inner retina while the outer retina remains normal (196,197). The 
oscillatory potentials, possibly originating from the amacrine cells of the inner plexiform 
layer (198), are sensitive to early DR changes, while the most commonly measured a and 
b waves - originating from the photoreceptors and inner retina, respectively - remain 
normal (197).Visual acuity and contrast sensitivity can be studied in animals by 
monitoring the optomotor response to rotating visual stimulation which induces reflexive 
turning of the head and neck (199-201).  
5.1.1 Retinal and Choroidal Blood Flow in Diabetes 
Diabetes causes damage to the microvasculature, and is of particular concern in 
the retina. Measurements of rBF and chBF in DR have yielded conflicting results. 
Reports show decreased BF, increased BF, or no changes in BF due to diabetes. Possible 
reasons for this inconsistency include i) type or model of diabetes (type 1 or 2 diabetes, 
toxin induced or genetic animal models, etc.), ii) duration and stage of retinopathy 
(diabetes with no clinical signs of retinopathy, early stage retinopathy, proliferative 
retinopathy, macular edema, etc.), iii) treatment (insulin to maintain normal blood 
glucose levels), iv) techniques for measuring blood flow (laser Doppler velocimetry, laser 
Doppler flowmetry, fluorescein angiography), v) the location of measurement (arteries, 
capillaries, venules, tissue, etc.), and vi) the type of parameters measured (velocity or 
circulation time of exogenous dyes, erythrocyte velocity or flow rates, blood volume, 
vessel size, etc.). 
In human patients, BF of the retina in diabetes has been studied mostly using laser 
Doppler velocimetry and fluorescein angiography and is usually reported to either 
increase or not change in diabetes. A spectrum of diabetic patients, ranging from no 
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retinopathy to severe retinopathy, had no changes in blood velocity, BF, and arteriolar 
diameter of the retinal vasculature (2,177). Other studies report that total BF to the retina 
is increased in diabetic patients with no or mild retinopathy (3,178,179), while blood 
velocity in retinal veins was unchanged (178,179). However, decreased blood velocity in 
retinal veins and arteries of diabetic patients is also reported (4). In the choroid, blood 
volume and BF were lower in proliferative diabetic retinopathy, while blood velocity is 
unchanged (106). 
Most often, rBF is reported to be lower in rodent models of diabetes. In non-obese 
diabetic mice, BF in retinal arteries of diabetic mice was lower (187). In STZ mice, 
retinal blood velocity and vessel diameter were reduced compared to controls (202). In 
STZ rats, retinal blood velocity was lower as well (30). In another study with STZ rats, 
blood flow and vessel diameter of retinal arteries were lower while blood velocity in the 
arteries was unchanged (203). In an alloxan induced model of diabetes in dogs, rBF was 
lower in diabetic animals (147). chBF may also be altered in animal models of diabetes. 
In the choriocapillaris, red blood cell velocity and flux were lower in STZ rats, while 
vessel diameter is not changed (204). Increased BF has also been reported in rodent 
models. In the genetic db/db mouse model of type 2 diabetes, red blood cell velocity was 
increased in the retinal capillaries of diabetic mice (188). Using the microsphere and 
hydrogen clearance methods, rBF and BF of the combined choroid/sclera were increased 
in STZ rats (205,206). 
5.1.2 The Ins2Akita Mouse Model of Diabetes 
The Akita mouse is a genetic model of Type 1 diabetes that develops many retinal 
complications (207-209). The Akita mouse has a point mutation in the insulin 2 gene 
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which leads to misfolding of the insulin 2 protein. Mice heterozygous for this mutation 
have severely reduced levels of insulin, despite the presence of a remaining wild-type 
insulin 2 allele and two alleles for insulin 1. The misfolded protein leads to its 
accumulation in pancreatic β cells and disruption of transport mechanisms within the 
cells (186,210). This results in disruption and death of the β cells causing hypoinsulemia, 
hyperglycemia, and diabetes. Male mice heterozygous for the Ins2
Akita
 mutation 
consistently develop hyperglycemia (186). 
Akita mice become hyperglycemic at about 4 weeks old (207). They begin to 
show signs of diabetic retinopathy by 1-3 months after onset of hyperglycemia (207,208). 
These mice have neuronal damage in the retina as indicated by increased apoptosis in the 
retina, reduced retinal ganglion cell and amacrine cell number, and eventual thinning of 
the inner plexiform and inner nuclear layers. Some vascular abnormalities also occur in 
the Akita mouse retina, including increased retinal vascular permeability and acellular 
capillaries (207,208). 
5.2 Methods 
 Animal preparation: Experiments were performed on male mice heterozygous for 
the Ins2
Akita
 mutation on a C57BL/6J background (Jackson Laboratory, Bar Harbor, 
Maine). Wild type littermates lacking the Ins2
Akita
 mutation were used for controls. To 
confirm hyperglycemia, blood glucose was measured using a blood glucose meter 
(AlphaTrak; Abbott Labs; Abbott Park, IL) at 4.5 weeks of age. Blood glucose > 250 
mg/dl was considered to be hyperglycemic.  
MRI was performed on mice at 30-37 weeks of age (n = 9 Akita, n = 8 wild type). 
Optomotor responses of awake, freely moving animals were determined at 29-32 weeks 
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of age (n = 10 Akita, n = 8 wild type). MRI and visual tests were performed on the same 
mice except visual tests were performed on 1 Akita mouse and 1 wild type mouse 
without MRI, and MRI was performed on 1 wild type mouse without visual tests. The 
visual acuity measurement from 1 wild type mouse was excluded from analysis due to an 
unreasonable value being recorded. 
 MRI methods: For MRI, animals were placed into a head holder with ear and 
tooth bars. Imaging was performed under 1.1-1.4% isoflurane, 30% oxygen with balance 
nitrogen, and spontaneous breathing conditions. A circulating warm water pad was used 
to maintain rectal temperature at 37 ± 0.5° C. Mice were prepared in a lit room before 
being transferred to the MRI room, in which lights were turned off. Lighting conditions 
were not changed during the duration of imaging. Breath rate, heart rate, and oxygen 
saturation were monitored and maintained (MouseOx, STARR Life Science Corp., 
Oakmont, PA). 
MRI studies were performed on a 7 Tesla, 30 cm horizontal magnet and a 150 
G/cm BGA6S gradient insert (Bruker, Billerica, Massachusetts). For imaging, a small 
circular surface eye coil with active decoupling (diameter = 6 mm) was placed over the 
left eye. A circular labeling coil (diameter = 8 mm) was placed at the heart position for a 
cardiac spin labeling technique as previously described (114). The two coils were 
separated by 2.3 cm from center to center.  
BF MRI was acquired using two-coil continuous ASL with an echo planar 
imaging (EPI) sequence. Paired images, one with and one without labeling, were 
acquired in an interleaved fashion. ASL employed a 2.6 s square radio frequency pulse to 
the labeling coil in the presence of a 2.0 G/cm gradient along the flow direction with a 
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post label delay of 350 ms. The sign of the frequency offset was switched for non-labeled 
images. Images were acquired in a coronal orientation with a single slice passing through 
the optic nerve head, with the slice angled perpendicular to the retina. Two-segment, 
gradient-echo EPI was used with field of view = 6.0x6.0 mm
2
, matrix = 144x144 (42x42 
µm2 resolution), a single 0.4 mm slice, TR = 3.0 s per segment, and TE = 12.6 ms. For 
each scan, 100 pairs of images were acquired in time-series with a total acquisition time 
of 20 min. 
 Visual acuity and contrast sensitivity measurements: Visual acuity and contrast 
sensitivity were assessed in mice by measuring the optomotor response to drifting 
gratings (199-201) using the OptoMotry system (Cerebral Mechanics, Inc., Lethbridge, 
Canada). The mouse was placed on a platform in the center of a chamber made of 
computer monitors. A virtual cylinder of sinusoidal gratings rotating at 12 degrees/sec 
was displayed on the monitors. The mouse is watched via an overhead video camera to 
determine if the head turns in response to the rotating gratings. A cursor placed at the 
animal’s head is used to center the virtual cylinder at the animal’s head. Both eyes can be 
tested since the left and right eyes are most sensitive to clockwise and counterclockwise 
rotations, respectively. Visual function was assessed in the left eyes of the mice (same 
eye as MRI).  
To test for acuity, 100% contrast was used while the spatial frequency of the 
gratings (in cycles/degree (cpd)) was varied using a stair-step protocol with a minimum 
step size of 0.003 cpd. A threshold was reported by the OptoMotry software as the 
contrast at which a head turn in response to the stimulus was observed in 70% of trials. 
Contrast sensitivity was assessed in a similar way at two spatial frequencies, 0.103 and 
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0.064 cpd, and with a minimum step size of 0.1%. These values encompass the spatial 
frequency that gives the peak sensitivity in C57BL6 mice (199). Contrast was calculated 
as (max-min)/(max+min), where max and min are the maximum and minimum values of 
the sinusoidal gratings. The contrast threshold was the contrast level where responses 
were observed in 70% of trials. 
 MRI image analysis: Image analysis was done using codes written in Matlab 
(Math-Works, Natick, MA), STIMULATE software (University of Minnesota), and 
Statistical Parametric Mapping 5 (SPM5) software. Images were zero-padded to 256x256 
(nominal resolution of 23x23 µm2) before subsequent processing. All images from each 
scan were acquired as time series, aligned using the spatial realignment function in SPM5 
and averaged off line.  
Blood flow images in units of (ml blood)/(g tissue)/min were calculated pixel-by-
pixel using Eq. 1.1. λ, the water tissue-blood partition coefficient, was taken to be 0.9, the 
same as the brain (64). The retina and choroid T1 at 7 T was taken to be 1.8 s which is 
similar to brain T1 (68). The labeling efficiency α was previously measured to be 0.7 (see 
Chapter 2) (114). 
BF intensity profiles across the retinal thickness were obtained from BF images 
by radially projecting lines perpendicular to the retina with profiles obtained at 4x spatial 
interpolation (9,139). Further motion correction was performed on the extracted profiles 
in Matlab (see Section 4.2). BF profiles were averaged along the length of the retina, 
excluding the optic nerve head. Measurements of peak values and layer thicknesses – 
defined as half-height width of BF peaks – were determined from the average BF profiles 
for each animal. The average length of the retina used for profile analysis was 2516 ± 45 
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µm in the Akita mice (n = 9) and 2543 ± 111 µm in wild type mice (n = 8, mean ± 
standard deviation (SD)). 
Data analysis: Group-average data were tabulated and expressed as mean ± SD. 
Two-sided t-tests with p < 0.05 indicating statistical significance were used to compare 
means of rBF, chBF, spatial frequency, and contrast sensitivity. Thickness measurements 
from MRI were compared between Akita and wild type mice using the Wilcoxon rank-
sum test. Correlation and linear regression were used on values of rBF, chBF, spatial 
frequency, and contrast sensitivity to analyze possible relations between the different 
measurements.  
5.3 Results 
Physiological parameters measured from the mice are summarized in Table 5.1. 
Mice with blood glucose > 250 dg/ml were considered to be hyperglycemic. At 5 weeks 
of age the mice with the Ins2
Akita
 mutation already had raised blood glucose. The Akita 
mice also had significantly lower body mass compared to controls at the time of MRI 
measurements. The wild type mice were imaged under ~1.4 % isoflurane, while the Akita 
mice were imaged under ~1.1 % to maintain their physiology close to that of the wild 
type mice. The Akita mice required less isoflurane likely due to diabetes and their smaller 
body mass. Despite this the respiration rate of the Akita mice was still slightly but 
significantly lower than controls (p = 0.04). Heart rate and oxygen saturation were not 
different between the wild type and Akita mice. 
With a resolution of 42x42x400 µm3, two distinct BF layers in the retina were 
resolved, separated by a region of low BF contrast (Figure 5.1 A). The outer BF layer, 
which corresponds to the choroid, had very high BF. The inner BF layer, which 
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corresponds to the retinal vessels, had substantially lower BF than the choroid. The 
middle layer with little to no BF contrast corresponds to the avascular region, made up of 
the outer nuclear layer and the outer and inner photoreceptor segments. 
 
 
Table 5.1: Physiological parameters in Akita and wild type mice (mean ± SD, WT - wild type)  
*p < 1E-6, **p < 0.05 between wild type and Akita 
 
WT Akita n (WT) n (Akita) 
Blood Glucose (mg/dl, at 4.5 wks) * 193 ± 36  461 ± 58  9  9  
Age (wks, at time of MRI) 32 ± 2.1 33 ± 2.4 8 9 
Age (wks, at time of visual tests) 29 ± 0.2  30 ± 1.7  8 10 
Weight (g, at time of MRI) * 32 ± 2.1 24 ± 1.4 8  9  
Respiration Rate (breaths/min) ** 109 ± 7.4  99 ± 10.2 8  9  
Heart Rate (beats/min) 435 ± 47 407 ± 38 8  9  


































Figure 5.1: (A) Blood flow image from a wild type mouse at 42x42x400 µm3 showing the retinal 
and choroidal blood flow. Intensity is scaled from 0 to 7 ml/g/min. (B) Group averaged blood 
flow profiles from Akita (n = 9) and wild type mice (n = 8). Two distinct peaks are present, 




Group averaged BF profiles from Akita and wild type mice are shown in Figure 
5.1 B. Overall, BF was lower in the Akita retina compared to wild type. BF values of the 
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retina and choroid in Akita and wild type mice are summarized in Table 5.2 and Figure 
5.2. rBF was lower by 0.45 ± 0.48 ml/g/min or 33% in Akita mice compared to wild 
types (p = 0.018, n = 9 Akita and 8 wild type). chBF was lower by 2.96 ± 3.94 ml/g/min 
or 32% in Akita mice compared to wild type (p = 0.054, n = 9 Akita and 8 wild type).  
 
 
Table 5.2: Blood flow (n = 8 wild type, n = 9 Akita) and optomotry (n = 8 wild type, n = 10 
Akita) results in wild type and Akita mice (mean ± SD) 
* p < 0.05, ** p <  0.01 between wild type and Akita 





Retinal BF (ml/g/min)*  1.4 ± 0.4 0.9 ± 0.3 -0.5 ± 0.5 -33 
Choroidal BF (ml/g/min) 9.4 ± 3.4 6.4 ± 2.0 -3.0 ± 3.9 -32 
Acuity (cycles/degree)**  0.42 ± 0.04 0.33 ± 0.06 -0.088 ± 0.070 -21 
Contrast Threshold, 0.103 (%)**  2.2 ± 0.7 6.7 ± 4.4 4.6 ± 4.5 213 




















































































Figure 5.2: (A) Retinal blood flow and (B) choroidal blood flow in wild type (n = 8) and Akita (n 
= 9) mice. (C) Visual acuity and (D) contrast sensitivity in wild type (n = 8) and Akita (n = 10) 
mice (mean ± SD). *p < 0.05 compared to wild type mice. 
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Based on the BF profiles, thicknesses of the retinal and choroid vascular layers 
and the avascular layer in between were estimated (Table 5.3). The thicknesses of the 
neural retina and choroid were about 165 µm and 70 µm, respectively. There were no 
significant differences in thicknesses between wild type and Akita mice (p > 0.05). 
 
 
Table 5.3: Thicknesses of retinal and choroidal vascular layers and the avascular layer (µm, 
mean ± SD, n = 8 wild type, n = 9 Akita). Neural Retina is the sum of the Retinal Vascular Layer 
and Avascular Layer. Retinal-Choroidal Peak Separation is the distance from the BF peak of the 
Retinal Vascular to the BF peak of the Choroidal Vascular Layer 
  Wild Type Akita 
Retinal Vascular Layer 62 ± 11 65 ± 13 
Avascular Layer 102 ± 8 105 ± 11 
Choroidal Vascular Layer 74 ± 3  69 ± 6 
Neural Retina 164 ± 16 169 ± 18 




Visual acuity and contrast thresholds are summarized in Table 5.2. The visual 
acuity measurement of one wild type mouse was excluded from analysis due to an 
obviously unrealistic reading, which likely came from user error. The visual acuity of 
Akita mice was significantly worse than wild types, measured as a decrease in the spatial 
frequency threshold (p = 0.002, n = 10 Akita and 7 wild type). The contrast thresholds 
with grating sizes of 0.064 and 0.103 cpd were both significantly worse in the Akita 
mice, measured as a larger contrast threshold (p = 0.023 and 0.009, respectively). The 
contrast thresholds with gratings of 0.064 and 0.103 cpd were not significantly different 
from each other in either the Akita or wild type mice (p > 0.05). 
Figure 5.3 shows scatter plots and linear fits of rBF, chBF, acuity, contrast 
threshold at 0.064 cpd, and contrast threshold at 0.103 cpd for the Akita and wild type 

































































































Figure 5.3: Scatter plots of rBF, chBF, visual acuity (acuity), and contrast threshold at 0.064 cpd (CT, 0.064) and 0.103 cpd (CT, 0.103) in wild 
type (n = 8 for rBF and chBF, 6 for acuity, 7 for both contrast thresholds) and Akita (n = 9 for all) mice. R
2
 is shown for each plot. 
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mice, but not the Akita mice. In the wild type mice, higher BF tended to correlate with 
better performance in the visual behavior tasks (higher acuity or lower contrast 
thresholds). The Akita mice appear to have more variability in these measurements than 
the wild types. In both Akita and wild type mice, rBF and chBF correlated with each 
other. The 3 measures of vision tended to correlate with each other in both Akita and wild 
type mice. 
5.4 Discussion 
MRI detected laminar specific BF differences in the retina of hyperglycemic 
Akita mice compared to age-matched controls at 7-8 months of age. Retinal BF was 
lower in the Akita mouse retina compared to age-matched controls. chBF was also lower 
but not significantly. No significant differences in retinal and choroidal thicknesses were 
found between control and Akita mice, measured from MRI. The visual acuity and 
contrast sensitivities to rotating gratings were significantly worse in the hyperglycemic 
mice compared to wild type controls. In wild type mice, higher BF tended to correlate 
with better vision, while in Akita mice, BF and vision had little correlation. These 
findings demonstrate further evidence of diabetic retinopathy in the Akita mouse 
Thicknesses: There were no differences in thicknesses of the retina of Akita and 
wild type mice, as measured from the BF MRI. Histological measurements of thickness 
have shown thinning of the inner plexiform and inner nuclear layers in Akita mice (by 
around 5-20 µm) (207). With an actual MRI resolution of 42x42 µm2, it is unlikely that 
such subtle changes presumably present in the diabetic retinas would be detected. 
Visual function: Visual acuity and contrast sensitivity were worse in the 7-8 
month old Akita mice. Visual deficits can occur in human diabetic patients before clinical 
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signs of diabetic retinopathy (191), including deficits in contrast sensitivity (192) and 
color sensitivity (193). Changes in ERG have also been noted in human DR, particularly 
in the oscillatory potentials and scotopic threshold (194,195,211) which arise from inner 
retinal activity. The ERG of STZ rats have similar deficits in the oscillatory potentials 
and scotopic threshold (196,197). Reports of visual tests in animal models of DR could 
not be found for comparison to the reduced visual acuity and contrast sensitivity found in 
Akita mice. Finally, since visual function was assessed with a behavioral test, deficits 
elsewhere, such as the brain or muscles, could influence the results. As such it is not 
entirely certain visual deficits in Akita mice arose from the retina. 
Blood flow in diabetes: At 7-8 months of age, rBF was significantly lower in the 
Akita mice. While chBF was also reduced, the change was not significant. These results 
are consistent with previous studies in other animal models of diabetes, which 
demonstrated reduced retinal blood flow, blood velocity, and vessel size (30,187,202-
204). Decreased measures of rBF has been found in the non-obese diabetic mouse (187), 
STZ-induced diabetic mice (202), STZ-induced diabetic rats (30,203). However, there are 
also some reports of increased rBF in rodent models, including the db/db mouse (188) 
and STZ rat (205,206). 
In the choroid, decreased BF has been reported in humans (106). However, in 
STZ rats, chBF has been reported to both decrease (204) and increase (205) in diabetic 
animals. Most animal models induce diabetes with the toxins STZ or alloxan, and 
reported studies of BF in these animals are commonly performed only a few weeks after 
induction of hyperglycemia (30,187,202-204). As such it is uncertain how relevant these 
previous studies are to the aged genetic model of diabetes used herein.  
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Akita mice have neuronal and some vascular signs of diabetic retinopathy mainly 
localized to the inner retina by 2-3 months of age (207). The oxygen of the outer retina is 
mainly supplied by the choroidal vasculature, while the oxygen of the inner retina comes 
from the retinal vasculature (24,157). Thus, the finding of lower rBF is consistent with 
the previous reports of inner retinal damage in the Akita mice (207). 
A possible confounding factor of the BF measurements is the lower isoflurane 
levels used in the Akita mice (1.1%) compared to wild type mice (1.4%). Isoflurane is a 
vasodilator (136), and there is some evidence that it can increase BF of the combined 
retina/choroid (100). However, in STZ diabetic rats, the minimum alveolar concentration 
of isoflurane and halothane is reduced in diabetics (212,213). Further, diabetic patients 
have more severe drops in mean arterial blood pressure under isoflurane/nitrous oxide 
anesthesia compared to non-diabetics with the same anesthesia regimen (214). Since 
isoflurane causes blood pressure to drop due to vasodilation, this suggests the diabetic 
patients may have had more extensive vasodilation. Also, the wild type mice were much 
heavier and appeared to have more body fat, so they may require higher isoflurane levels 
due to this. Thus it is expected that the diabetic Akita mice would need lower levels of 
isoflurane to maintain the same depth of anesthesia as normal wild type mice. 
Additionally, the respiration rate of the Akita mice was modestly, but 
significantly, lower during anesthesia. Lower respiration rate would cause hypoxia and 
hypercapnia which could cause increased BF, although oxygen saturation measurements 
suggest no differences in oxygenation between the Akita and wild type mice. 
Blood flow and visual tests: Comparison of BF measurements and visual tests, 
suggest that higher BF in the retina / choroid and better visual acuity / contrast sensitivity 
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are correlated in wild type mice. In Akita mice, however, this relationship was disrupted. 
Despite the fact that BF tended to be lower and vision tended to be worse in Akita mice, 
these changes were weakly correlated to each other.  
Although diabetic retinopathy has been traditionally thought of mostly as a 
disease of the vasculature, there is evidence that neuronal damage occurs in the retina 
independent of and possibly prior to vascular abnormality (182). Hyperglycemic Akita 
mice have been shown to have neuronal damage in the retina by 2-3 months of age (207). 
It may thus be possible that the vision deficit in the Akita mice is mainly due to direct 
neuronal damage, independent of damage to the microvasculature and altered BF to the 
retina. Both hyperglycemia and hypoinsulemia may possibly be damaging to retinal 
neurons (182,183). Alternatively, if the visual tests were influenced by deficits in the 
brain or muscles of Akita mice, then the measured visual deficit could be entirely 
unrelated to rBF and chBF.  
5.5 Conclusions 
 ASL MRI was used to investigate retinal and choroidal BF in the Ins2
Akita
 mouse 
model of diabetes. In addition, visual function was assessed in the hyperglycemic Akita 
mice, testing visual acuity and contrast sensitivity. In aged Akita mice, retinal BF was 
lower and acuity and contrast sensitivity were worse, indicating retinopathy. However, 
the reduction in BF and worsening of vision did not seem to be correlated in the Akita 
mice, suggesting these changes may occur through independent mechanisms. Further 
studies are needed to determine the effects of Akita at earlier time points and to 
corroborate the unique BF and visual findings in the Akita mouse. 
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CHAPTER 6 
MRI OF RETINAL DEGENERATION 
 
Retinitis pigmentosa is the most common inherited retinal degeneration, affecting 
1.5 million people worldwide (215). It consists of a group of retinal dystrophies that 
cause photoreceptor death and blindness (216). There is some evidence of vascular 
disruption in the retina (7,10,217). While perturbations of the vasculature and blood flow 
of the retina and choroid are known to be significant factors in some retinal diseases, such 
as diabetic retinopathy (1) and glaucoma (5), these factors have not been extensively 
studied in retinal degeneration. 
The cardiac ASL method could non-invasively image blood flow of the retina and 
choroid, so the method was utilized to study BF changes in retinal degeneration. MRI 
was utilized to image quantitative, layer-specific retinal blood flow (rBF) and choroidal 
blood flow (chBF) in the rd10 mouse model of retinal degeneration at different stages of 
degeneration. Anatomical MRI was also obtained to monitor changes in retinal and 
choroidal thickness over time and compared to histological measurements. 
6.1 Retinal Degeneration and Retinitis Pigmentosa 
 Retinitis pigmentosa is group of inherited diseases of the retina which causes 
retinal degeneration and vision loss. It is characterized initially by a progressive loss of 
photoreceptors, usually affecting the rods first, followed by a secondary loss of cones. 
Retinitis pigmentosa begins with loss of peripheral vision and impaired night vision due 
to the loss of rods and progresses to loss of the central visual field and complete blindness 
(215). In addition to the photoreceptors, other neural and synaptic layers in the retina 
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deteriorate slowly over time (218). A large number of mutations in many different genes 
which cause retinitis pigmentosa have been described, including the genes for rhodopsin, 
mertk, and phosphodiesterase β (216,218,219). 
 The retinal vasculature has been found to atrophy in retinal degeneration 
(10,220,221), often considered to be a secondary effect of photoreceptor loss. It is has 
been proposed that extensive loss of the photoreceptors, which have a high metabolic 
rate, causes hyperoxia in the retina which in turn may attenuate the retinal vasculature 
(157,222). Further, light exposure can accelerate degeneration (223,224), while reduction 
of light can slow or possibly reverse degeneration (223). It has been suggested that the 
effects of light are mediated through retinal oxygenation, since oxygen is increased under 
light compared to dark conditions (23). However, hyperbaric oxygen therapy preserves 
vision in retinitis pigmentosa patients, suggesting the retina is hypoxic, leading to 
increased photoreceptor degeneration (225). Additionally, injection of hematopoietic 
stem cells into the eye of rd mice prior to degeneration, rescued retinal vasculature from 
atrophy, reduced degeneration of the outer retina, and preserved some electroretinogram 
(ERG) response (10). This suggests that vasculature dysfunction may have an important 
role in early stages of and progression of retinal degeneration. 
Although the vasculature is known to be affected retinal degenerations, BF of the 
retina and choroid has rarely been studied. In humans, diameter, blood velocity, and 
blood flow in retinal veins were all substantially lower in retinitis pigmentosa patients, as 
well as total retinal BF (217). In a cat model of retinitis pigmentosa, rBF was 
compromised while chBF was not significantly affected (7). In human patients the ocular 
pulse amplitude, used as an indication of chBF, was reduced in later stages of the disease, 
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but not early (226). chBF was also reported to be lower  in patients with retinitis 
pigmentosa as measured by laser Doppler flowmetry (227). A study using MRI to image 
combined retinal/choroidal BF in the RCS rat model of retinal degeneration, found that 
the combined BF was lower in the animals with retinal degeneration (8).  
The regulation of the retinal and choroidal vasculature may potentially be altered 
in retinitis pigmentosa as well. A study using BOLD fMRI found attenuated retinal and 
choroidal responses to hyperoxia and hypercapnia in the RCS rat model of retinal 
degeneration (9). BF changes of the combined retina/choroid due to hyperoxic and 
hypercapnic challenges were also attenuated in RCS rats (8). In human patients, however, 
the retinal vascular response to hyperoxia was not altered (217). These studies suggest 
that the retinal and choroidal vasculature may play an important role in retinal 
degeneration. 
6.1.1 The rd10 Mouse Model of Retinal Degeneration 
 The rd10 mouse is an animal model of retinal degeneration (228-230). Retinal 
degeneration begins in rd10 mice about post natal 16 days and is complete by 60 days 
(229,230). Degeneration of the outer retina (outer nuclear layer and inner and outer 
segments) begins first with remodeling of the inner retina occurring later (230). The outer 
nuclear layer and inner and outer segments eventually completely degenerate by post 
natal 60 days (229). 
rd10 mice have a mutation in the Pde6b gene, encoding a subunit of the rod 
phosphodiesterase (228,229). Similarly, mutations in the gene for the β subunit of the rod 
phosphodiesterase have been found in human cases of autosomal recessive retinitis 
pigmentosa (219,231). In the normal retina, the absorption of photons in the 
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photoreceptors results in the activation of the phosphodiesterase, which degrades cyclic 
guanosine monophosphate (GMP) causing the closure of cyclic GMP gated ion channels. 
The mutation in the Pde6b gene causes deficient activity of the rod phosphodiesterase 
which results in the accumulation of cyclic GMP and death of rod cells (229). The rd10 
mouse has a mutation in the same gene as mice with the rd1 mutation, present in some 
common strains of  mice, but the rd10 mutation produces a milder degeneration with later 
onset (229). 
 Changes in other cellular and vascular layers occur, likely secondary to 
photoreceptor loss (10,218,230). The retinal vessels atrophy in the rd10 mouse model of 
retinal degeneration; injection of hematopoietic stem cells rescues retinal vessels from 
degradation and also rescues cellular layers of the retina including the cones of the 
photoreceptors, suggesting vascular dysfunction may be partially responsible for 
degeneration in this model (10). Electroretinography has shown that functional deficits 
are present in photoreceptors of rd10 mice from birth, but further decline in function 
occurs progressively eventually becoming undetectable (229). 
6.2 Methods 
 Animal preparation: Experiments were performed on mice homozygous for the 
Pde6b mutation bred onto a C57BL/6J background (Jackson Laboratory, Bar Harbor, 
Maine). For controls, normal age-matched C57BL/6J mice were used (Jackson 
Laboratory, Bar Harbor, Maine). MRI and histology were performed on mice at post-
natal ages 25, 35, and 60 days. 
 For MRI, animals were placed into a head holder with ear and tooth bars. Blood 
flow imaging was performed under 1.0-1.1% isoflurane, 30% oxygen with balance 
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nitrogen, and spontaneous breathing conditions. For high resolution anatomical imaging 
urethane anesthesia was used (1.5 g/kg, intraperitoneal) and isoflurane discontinued. 
Under isoflurane alone, the eye is prone to motion (140), while urethane is effective at 
minimizing motion. The high resolution anatomical MR images had relatively long times 
to acquire a single image and low signal to noise (making motion correction perform 
worse), so preventing motion was much more important.  A circulating warm water pad 
was used to maintain rectal temperature at 37 ± 0.5° C. Mice were prepared in a lit room 
before being transferred to the MRI room, in which lights were turned off. Lighting 
conditions were not changed during the duration of imaging. Breath rate, heart rate, and 
oxygen saturation were monitored during imaging (MouseOx, STARR Life Science 
Corp., Oakmont, PA). 
MRI methods: MRI studies were performed on a 7 Tesla, 12 cm horizontal magnet 
and a 150 G/cm BGA6S gradient insert (Bruker, Billerica, Massachusetts). For imaging, 
a small circular surface eye coil with active decoupling (diameter = 6 mm) was placed 
over the left eye. A circular labeling coil (diameter = 8 mm) was placed at the heart 
position for a cardiac spin labeling technique as previously described (114). The two coils 
were separated by 2.3 cm from center to center.  
BF MRI was acquired using two-coil continuous ASL with an EPI sequence. 
Paired images, one with and one without labeling, were acquired in an interleaved 
fashion. ASL employed a 2.6 s square radio frequency pulse to the labeling coil in the 
presence of 2.0 G/cm gradient along the flow direction with a post label delay of 350 ms. 
The sign of the frequency offset was switched for non-labeled images. Images were 
acquired in a coronal orientation with a single slice passing through the optic nerve head, 
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with the slice angled perpendicular to the retina. Two-segment, gradient-echo EPI was 
used with field of view = 6.0x6.0 mm
2
, matrix = 144x144 (42x42 µm2 resolution), a 
single 0.4 mm slice, TR = 3.0 s per segment, and TE = 9.7 in 25 and 60 day old mice or 
12.6 ms for 35 day old mice. For each scan, 100 pairs of images were typically acquired 
in time-series with a total acquisition time of 20 min. 
Anatomical images were acquired using a balanced steady state free precession 
(bSSFP) sequence at low and high resolutions. Low resolution scans were obtained with 
field of view = 5x5 mm
2
, matrix = 120x120 (42x42 µm2), a single 0.4 mm slice, and 
TE/TR = 3.6/7.2 ms. Data were oversampled by a factor of 2 in both frequency and phase 
encode directions. Fifty repetitions were acquired in time-series with 3 averages per 
repetition for an acquisition time of about 4.5 min. High resolution scans were obtained 
with a 3D acquisition with field of view = 4.48x4.48x3.2 mm
3
, matrix = 128x128x16 
(35x35x200 µm2), and TE/TR = 3.3/6.5 ms. Data were oversampled by a factor of 2 in 
the frequency and first phase encode directions. Sixty four repetitions were acquired in 
time-series for an acquisition time of about 30 min. 
Histology: At the end of the MRI session, the mice were euthanized, and eyes 
were enucleated and placed in 10% paraformaldehyde overnight. Eyes were then 
dehydrated with washes of ethanol and xylene. Whole eyes were embedded in paraffin 
and sectioned at 8 µm on a microtome. Multiple slices through the optic nerve were 
obtained and stained using hematoxylin and eosin. Thickness measurements were made 
at 100x from 2 different slices about 200-300 µm away from the optic nerve head and on 
both sides of the optic nerve. 
 89
Data analysis: Image analysis was done using codes written in Matlab (Math-
Works, Natick, MA), STIMULATE software (University of Minnesota), and Statistical 
Parametric Mapping 5 (SPM5) software. Blood flow images were zero-padded to 
256x256 (nominal resolution of 23x23 µm2) before Fourier transform into imaging space. 
Anatomical images were zero-padded to 128x128 (nominal resolution of 39x39 µm2). 
High resolution anatomical images were zero-padded to 256x256 (nominal resolution of 
18x18 µm2). Images were acquired in time series, aligned using the spatial realignment 
function in SPM5 and averaged off line. For the high resolution anatomical images, 
realignment and averaging was performed on the complex-valued images, which 
provided substantially better image quality and contrast to noise than if only the 
magnitude images were used. 
Blood flow images of the eye, in units of ml/g/min, were calculated pixel-by-pixel 
using Eq. 1.1. λ, the water tissue-blood partition coefficient, was taken to be 0.9, the 
same as the brain (64). The retina and choroid T1 at 7 T was taken to be 1.8 s (68). A 
value of 0.7 was used for α, the labeling efficiency, as was previously measured in the 
distal internal carotid arteries at the base of the frontal lobe (see Chapter 2) (114). 
BF intensity profiles across the retinal thickness were obtained from BF images 
by radially projecting lines perpendicular to the retina with profiles obtained at 4x spatial 
interpolation (9,139). Further motion correction was performed on the extracted profiles 
in Matlab (see Chapter 4.2). BF profiles were averaged along the length of the retina, 
excluding the optic nerve head. Anatomical profiles were averaged over two 273 µm long 
regions located on either side of the optic nerve head. Measurements of peak values and 
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layer thicknesses – defined as half-height width of anatomical or BF peaks – were 
determined from the average profiles for each animal. 
rBF and chBF data were analyzed separately using two-way ANOVA to analyze 
effects of mouse strain and age. Multiple comparisons were made using the Bonferroni 
correction. Thickness measurements from MRI were compared using the Wilcoxon rank-
sum test. Thickness measurements from histology were compared using two-way 
ANOVA or two-sided unpaired t-tests as specified. For all tests, p < 0.05 was considered 
significant. 
6.3 Results 
6.3.1 Anatomical MRI of Retinal Degeneration 
Anatomical images at 42x42x400 µm3 of a C57BL/6J and rd10 mouse at post 
natal 60 days are shown in Figure 6.1. Group average profiles from C57BL/6J and rd10 
mice at post natal 25, 35 and 60 days are shown in Figure 6.1 C. In the normal C57BL/6J 
mice, 4 layers were present in the retina (including a layer that was the choroid) at all 
ages. In rd10 mice at all ages there were only 2 layers (including a layer that was the 
choroid) in the retina. Thicknesses of MRI anatomical layers are summarized in Table 6.1 
and Figure 6.2.  
The thickness of the neural retina was significantly less in rd10 mice compared to 
age matched C57BL6/J mice at 25, 35 and 60 days (p < 0.05), but the thickness of the 
choroid (MRI layer 4) was not changed. In rd10 mice the neural retina was significantly 
thinner at 35 and 60 days compared to 25 day old rd10 mice (p < 0.01). The neural retina 
was also significantly thinner in 60 day old rd10 mice compared to 35 day old rd10 mice 
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(p < 0.05). However, the 10 µm difference in thickness is much less than the actual image 
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Figure 6.1: Anatomical images at 42x42x400 µm3 from a single (A) C57BL/6J mouse and (B) 
rd10 mouse at 60 days post natal. (C) The group average anatomical profiles for C57BL/6J mice 
at postnatal 25, 35, and 60 days (n = 4, 6, and 6, respectively) and for rd10 mice at postnatal 25, 
35, and 60 days (n = 4, 6, and 6, respectively). The choroid peaks from all profiles were aligned 
together. Four layers were present in the C57BL/6J retina, including the choroid (labeled 1-4 in 
red). Two layers were present in the rd10 retina, including the choroid (labeled 3-4 in blue). 
Layer 3 likely corresponds to different anatomical layers in the C57BL/6J and rd10 retina. The 
green arrows indicate the choroid (layer 4). The purple arrows indicate the vitreous-retina 









Table 6.1: Thicknesses of anatomical MRI layers at 42x42x400 µm3 from C57BL/6J and rd10 
mice (µm, mean ± SD). Neural Retina is the sum of MRI Layers 1, 2, and 3 
*p < 0.05, **p < 0.01 compared to age-matched C57BL6/J mice (statistical tests only used on 
Layer 4 and Neural Retina) 
Age 
(days) 
  MRI Layer Neural 
Retina Strain n Layer 1 Layer 2 Layer 3 Layer 4 
25 C57BL/6J 4 59 ± 8 42 ± 5 71 ± 5 59 ± 8 171 ± 6 
rd10 4 - - 105 ± 9 59 ± 0 105 ± 9* 
35 C57BL/6J 6 63 ± 11 45 ± 5 75 ± 5 64 ± 12 182 ± 8 
rd10 6 - - 75 ± 5 61 ± 4 75 ± 5** 
60 C57BL/6J 6 63 ± 8 46 ± 10 73 ± 16 56 ± 5 182 ± 10 

























Figure 6.2: Group average thicknesses of the neural retina (sum of MRI layers 1, 2, and 3) from 
anatomical MRI at 42x42x400 µm3 from C57BL/6J and rd10 mice at 25, 35, and 60 days post 





High resolution anatomical images at 35x35x200 µm3 of a C57BL/6J and rd10 
mouse at post natal 25 days are shown in Figure 6.3. Group average profiles from 
C57BL/6J and rd10 mice at post natal 25 days are shown in Figure 6.3 C. In the normal 
C57BL/6J mice, 6 layers were present in the retina at high resolution (including a layer 
that was the choroid). In rd10 mice, 4 layers were detected (including a layer that was the 
choroid) in the retina. Thicknesses of high-resolution MRI anatomical layers are 
summarized in Table 6.2. The thickness of the neural retina was significantly less in rd10 
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mice compared to age matched C57BL6/J mice (p < 0.05), but the thickness of the 









































Figure 6.3: Anatomical images at 35x35x200 µm3 from a (A) C57BL/6J and (B) rd10 mouse at 
25 days post natal. (C) The group average anatomical profiles for C57BL/6J and rd10 mice at 
post natal 25 days (n = 4 and 4, respectively). The choroid peaks from all profiles were aligned 
together. Six layers were present in the C57BL/6J retina, including the choroid (labeled 1-6 in 
red). Four layers were present in the rd10 retina, including the choroid (labeled 3-6 in blue). 
Layers 3-5 likely correspond to different anatomical layers in the C57BL/6J and rd10 retina. The 
green arrows indicate the choroid (layer 6). The purple arrows indicate the vitreous-retina 




Table 6.2: Thicknesses of anatomical MRI layers at 35x35x200 µm3 from C57BL/6J (n = 4) and 
rd10 (n = 4) mice at post natal 25 days (µm, mean ± SD). Neural Retina is the sum of MRI Layers 
1-5 
*p < 0.05 compared to age-matched C57BL6/J mice (statistical tests only used on Layer 6 and 
Neural Retina) 
Strain 
MRI Layer Neural 
Retina  Layer 1  Layer 2  Layer 3  Layer 4  Layer 5  Layer 6  
C57BL/6J 42 ± 3 34 ± 2 30 ± 3 29 ± 5 35 ± 0 40 ± 3 169 ± 3 
rd10 - - 38 ± 2 27 ± 3 33 ± 2 40 ± 3 98 ± 4* 
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Histology was acquired in the same mice as MRI at 25 and 60 days post natal 
(Figure 6.4). In 60 day old rd10 mice the inner and outer segments could not be detected. 
The outer nuclear and outer plexiform layers were substantially reduced to the point that 
they could not be cleanly distinguished from each other (so in this group a single value is 
reported for both layers). In 25 day old rd10 mice the inner and outer segments could not 
be distinguished from each other, so a single value is reported for both layers. Anatomical 
layer thicknesses are summarized in Table 6.3.  
 
rd10 C57BL/6J



















Figure 6.4: Histology of rd10 and C57BL/6J mouse retinas obtained at 40x magnification. GCL 
– ganglion cell and nerve fiber layers, IPL – inner plexiform layer, INL – inner nuclear layer, 




Two-way ANOVA was separately run on the total neural retina, GCL, IPL, INL. 
For OPL, ONL, IS, and OS, two-sided unpaired t-tests were used since these layers were 
missing in groups of the rd10 mice. With the layers that were combined in the rd10 mice, 
comparisons were made to the corresponding sum of the layers (ie OPL+ONL for the 60 
day old rd10 mice). Each layer of the 60 day old rd10 mouse was significantly thinner 
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compared to 25 and 60 day old C57BL/6J mice and 25 day old rd10 mice. In 25 day old 
rd10 mice, all of the outer layers of the retina were significantly thinner, while none of 
the inner retinal layers were changed. The only significant difference between 25 and 60 
day old C57BL/6J mice was the outer segment (p < 0.05, two-sided unpaired t-test). 
 
 
Table 6.3: Thicknesses of histological layers from C57BL/6J and rd10 mice (µm, mean ± SD). 
Neural Retina is the sum of all layers 
a
p < 0.05 between rd10 and age-matched C57BL/6J mice, 
b
p < 0.05 between 60 and 25 day old 
rd10 mice, 
c
p < 0.05 between 60 and 25 day old C57BL/6J mice 
Age 
(days)  
         Neural 
Retina  Strain n GCL IPL INL OPL ONL IS OS 
25 C57BL/6J 4 23 ± 3 55 ± 2 39 ± 3 16 ± 2 55 ± 2 18 ± 1 22 ± 2 229 ± 8 
rd10 4 20 ± 1 56 ± 2 41 ± 3 12 ± 1
a
 14 ± 1
a
 7 ± 1
a
 150 ± 5
a
 
60 C57BL/6J 6 22 ± 2 54 ± 3 41 ± 3 15 ± 1 56 ± 3 17 ± 2 26 ± 2
c
 231 ± 8 
rd10 6 16 ± 3
ab
 40 ± 3
ab
 32 ± 2
ab
 9.7 ± 2
ab





6.3.2 Blood Flow MRI of Retinal Degeneration 
BF images at 42x42x400 µm3 of a C57BL/6J and rd10 mouse at post natal 60 
days are shown in Figure 6.5. Group average BF profiles from C57BL/6J and rd10 mice 
at post natal 25, 35 and 60 days are shown in Figure 6.6. In the normal C57BL/6J mice at 
all ages, 2 BF peaks, corresponding to rBF and chBF, were present and were separated by 
a dip. In the rd10 mice, the chBF peak was easily distinguished at all ages, but the rBF 
peak was not as clear. At 25 days there was an obvious rBF layer, but it was not well 
separated from the chBF. At 35 days, there generally seemed to be a weak layer in the BF 
images that was likely the rBF, but it was not separated from the chBF and was generally 
difficult to distinguish from noise. At 60 days, rBF was even more difficult to detect, and 










Figure 6.5: Blood flow images at 42x42x400 µm3 from a single (A) C57BL/6J mouse and (B) 
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Figure 6.6: Group average BF profiles (top row) for rd10 and C57BL/6J mice at post natal (A) 
25 (n = 4 and 4, respectively), (B) 35 (n = 6 and 6, respectively), and (C) 60 days (n = 6 and 6, 
respectively). Error bars represent standard error of the mean. The bottom row is the 
corresponding group average anatomical profiles from the non-labeled EPI images. The chBF 
peak is marked by the green vertical lines and rBF peak is marked by the orange vertical lines. 
Two orange lines are shown in each plot to indicate the rBF layer of both C57BL/6J and rd10 
mice, which had different locations.  
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In the group averaged BF profiles, there was a small hump inside the choroid in 
the profile of the rd10 mice at 35 days that is probably the rBF layer, although there is no 
dip separating it from the chBF layer. At 60 days, even this small hump seemed to almost 
completely disappear, although rBF was not significantly different between the two ages. 
Values of rBF and chBF, as well as physiological parameters, are summarized in Table 
6.4 and Figure 6.7. None of the physiological parameters were significantly different 
between aged matched C57BL/6J and rd10 mice (p > 0.05, two-sided unpaired t- tests). 
The results of ANOVA showed that the strain had a significant effect on rBF (p < 
0.01) and chBF (p < 0.05). Age did not have a significant effect on rBF or chBF (p > 
0.05). The interaction of strain and age was significant for rBF (p > 0.05), but not chBF. 
Multiple comparisons of groups showed that rBF of 60 day old rd10 mice was 
significantly less than 35 and 60 day old C57BL/6J as well as 25 day old rd10 mice. 




Table 6.4: Retinal BF, choroidal BF, and physiological parameters during BF imaging from 
C57BL/6J and rd10 mice (mean ± SD). RR – respiration rate, HR – heart rate, SaO2 – arterial 
oxygen saturation 
a
p < 0.05, 
b
















(ml/g/min)    
25 C57BL/6J 4 14 ± 1 115 ± 6 507 ± 50 98.3 ± 0.6 5.0 ± 0.4
a
 0.9 ± 0.2 
rd10 4 12 ± 1 120 ± 9 421 ± 53 98.8 ± 0.5 7.0 ± 1.1 1.1 ± 0.2
B
 
35 C57BL/6J 6 18 ± 1 117 ± 6 475 ± 69 98.3 ± 0.3 6.8 ± 1.9 1.1 ± 0.6
B
 
rd10 6 19 ± 1 118 ± 10 430 ± 35 98.7 ± 0.4 8.3 ± 1.1
a
 0.7 ± 0.3 
60 C57BL/6J 6 20 ± 2 117 ± 4 483 ± 41 98.6 ± 0.4 6.7 ± 1.5 1.2 ± 0.2
B
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Figure 6.7: Group average (A) retinal and (B) choroidal BF in C57BL/6J and rd10 mice at 25, 
35, and 60 days post natal. Error bars represent standard deviation. 
a
p < 0.05, 
b







The retina of the rd10 mouse had substantial degeneration of the photoreceptors 
by post natal 25 days, resulting in a thinner retina measured by anatomical MRI and 
histology. The rd10 mouse retina underwent further thinning and degeneration at post 
natal 35 and 60 days. Retinal BF in the rd10 mouse was reduced at 60 days compared to 
age matched controls and 25 day old rd10 mice. However, choroidal BF was not affected 
in the rd10 mice at any stage of disease. 
 Retinal thickness and anatomical MRI: The neural retina was substantially thinner 
in the rd10 mice compared to age-matched controls. The thickness of the choroid did not 
change. Low resolution MR images (42x42x400 µm3) had 3 layers in the neural retina of 
normal C57BL/6J mice. The neural retina was reduced from 3 layers to 1 layer in rd10 
mice at all ages. Low resolution MRI could detect differences in retinal thickness at all 
ages of rd10 mice compared to age matched controls. The low resolution MRI could also 
clearly detect thinning of the rd10 retina over time, with the retina being substantially 
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thinner at 35 and 60 days compared to 25 days. High resolution MR images (35x35x200 
µm3) had 5 layers in the neural retina in normal C57BL/6J mice but only 3 layers in 25 
day old rd10 mice.  
 Both the low and high resolution anatomical MRI provided similar measurements 
of the neural retina thickness in 25 day old C57BL/6J (low – 171 µm, high – 169) and 
rd10 mice (low – 105 µm, high – 98 µm). However, the choroid seemed slightly thicker 
in the low resolution MRI (59 µm in both C57BL/6J and rd10 mice) compared to high 
resolution MRI (40 µm in both C57BL/6J and rd10 mice). The thickness of the neural 
retina measured from MRI was much less compared to histology from the 25 day old 
mice however (229 µm in C57BL/6J and 150 µm in rd10 mice). The difference in 
thickness between C57BL/6J and rd10 mice is similar measured from both MRI (66 µm) 
and histology (79 µm). 
At 60 days, the photoreceptors (outer nuclear layer and inner/outer segments) 
were almost completely gone in the histology. The neural retina was measured to be 
thinner from MRI (182 µm in C57BL/6J and 65 µm in rd10 mice) compared to histology 
(231 µm in C57BL/6J and 98 µm in rd10 mice). The difference in thickness between 
C57BL/6J and rd10 mice was 117 µm from MRI and 133 µm from histology, which is 
again more similar than the thicknesses. 
Possible reasons for the differences in thickness between MRI and histology 
include partial volume effects in the relatively low resolution MR images or distortion of 
the retina during fixation and sectioning. Regardless of the discrepancy between MRI and 
histology, both methods detected thinning of the retina in the 25 and 60 day old rd10 
mice. 
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 Blood flow measurement: In normal C57BL/6J mice, two separated BF layers, 
corresponding to rBF and chBF, could be distinguished. In 25 day old rd10 mice, the rBF 
and chBF layers were clearly present in all mice, but were not well separated. In two 25 
day old rd10 mice the two BF peaks were separated by a slight dip in the BF profile; in 
the other two 25 day old rd10 mice the two BF layers were not separated. In rd10 mice at 
35 and 60 days, the chBF layer was still clearly present, but the rBF layer was difficult to 
detect, particularly at 60 days. A small hump that was not separated from the chBF layer 
could generally be found at 35 days, but at 60 days, even this was essentially gone. Due 
to the loss of most of the avascular layer (outer nuclear layer and inner/outer segments), it 
is expected that the rBF and chBF would no longer be separated by a region of minimal 
BF.  
The difficulty in detecting the rBF layer could be due to reduced BF or 
insufficient resolution to detect the thinned retinal vascular layer. Both likely occur to 
some extent. Based on the anatomical profiles of the EPI images, the neural retina was 
still thick enough to be clearly distinguished. This suggests that rBF, if present, should 
still be able to be detected by MRI. The presence of the rBF layer in the 35 day old rd10 
mice supports this (since 35 and 60 day old rd10 mice had similar retinal thicknesses 
based off the low-resolution anatomical MRI).  
Partial volume of the rBF layer could affect comparison of quantitative rBF 
values between normal and thinned retina. The thinned retina of the rd10 mice could be 
more prone to partial volume with the avascular vitreous and highly vascularized choroid. 
Since the inner retina, where the retinal vasculature is located, is only modestly thinned in 
the rd10 mice, the partial volume from the vitreous to the rBF is likely not altered much. 
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The loss of most of the avascular outer retina moves the rBF layer much closer to the 
strong chBF peak, and likely introduces some amount of partial volume from the choroid. 
This would be expected to erroneously increase rBF, making detection of decreased rBF 
more difficult.  
Retinal and choroidal BF in retinal degeneration: In the rd10 mouse model of 
retinal degeneration, rBF had a trend of decreasing overtime, but was only significantly 
reduced at 60 days. chBF was unaffected in rd10 mice up to 60 days old. In 25 day old 
C57BL/6J mice, chBF was significantly lower compared to 35 day old rd10 mice. chBF 
was otherwise consistent between all groups. Due to the noisiness of the BF data, the lack 
of any other differences in chBF, and the small sample size, this difference is possibly not 
real and may disappear with larger samples. 
Previous studies of retinal degeneration have found decreased rBF and potentially 
decreased chBF. In humans, diameter, blood velocity, and blood flow in retinal veins 
were all lower in retinitis pigmentosa patients, as well as total rBF (217). In a cat model 
of retinitis pigmentosa, rBF was compromised while chBF was not significantly affected 
(7). However, in human patients, the ocular pulse amplitude, used as an indication of 
chBF, is reduced in later stages of the disease, but not early (226). 
Previous MRI studies in the RCS rat model of retinal degeneration have also 
found changes in BF. In a relatively low-resolution study imaging combined 
retinal/choroidal BF, the combined BF was lower in RCS rats with retinal degeneration 
(8). The combined retinal/choroidal BF signal in rats is probably dominated by the very 
high chBF, so the reduced BF found in RCS rats suggests possible changes in chBF in the 
model. However, in another study of the RCS rat with layer-specific BF of the retina and 
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choroid, chBF was not altered in the RCS rat (232). The rBF layer could be detected in 
normal rats but was absent in the RCS rats. It was unclear whether the resolution was 
insufficient to separate rBF from chBF, or if rBF was reduced so much as to be 
undetectable.  
There is evidence that the attenuation of retinal vasculature is due to hyperoxia in 
the retina caused by the loss of metabolically active photoreceptors 
(23,157,221,222,233). Using oxygen electrodes, RCS rats had higher oxygen in the 
remaining outer retina, increased flow of oxygen from the choroid to the inner retina, and 
reduced oxygen input from the retinal circulation (157,222,234). In a cat model of retinal 
degeneration, the inner retinal oxygen was not altered while the retinal vessels were 
attenuated (233). Contrary to these findings, hyperbaric oxygen therapy preserves vision 
in retinitis pigmentosa patients, suggesting retinal hypoxia which then leads to increased 
photoreceptor degeneration (225). Additionally, it has been found that injection of 
hematopoetic stem cells into the eye of rd mice prior to degeneration rescues retinal 
vasculature from atrophy, reduces degeneration of the outer retina, and preserves some 
electroretinogram (ERG) response (10). 
6.5 Conclusions 
High resolution MRI could detect anatomical and physiological changes at 
different stages of disease in the retina of the rd10 mouse model of retinal degeneration. 
Retinal blood flow was reduced at a late stage of retinal degeneration, while choroidal 
blood flow was unchanged. Future studies could measure functional BF changes to 
physiological stimulations. Since MRI provides a non-invasive method to pinpoint 
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anatomical and vascular changes in vivo, it could be used for longitudinal studies of 





This thesis detailed the development of MRI methods to image anatomy, function, 
and blood flow (BF) of the retina and choroid, and their application to two diseases of the 
retina: diabetic retinopathy and retinal degeneration. MRI provides anatomical, 
functional, and physiological images at relatively high spatial resolution, is non-invasive, 
and does not have depth limitation. MRI is widely used to study anatomy and physiology 
throughout the body due to these favorable properties. However, the application of MRI 
to study the retina is still difficult due to the very small size of the retina. The retina, 
which can be seen through the pupil, has thus traditionally been studied using optical 
techniques, which are mostly limited to probing the retinal surface. 
In order to image BF of the retina, a technique to image BF in mice with good 
sensitivity was needed. To perform BF imaging, a two-coil continuous arterial spin 
labeling (ASL) technique was developed and applied to image cerebral blood flow in 
mice. Two-coil continuous ASL has been employed in rats (13,103), humans (69), and 
monkeys (70,104), but it had not yet been extended to mice. The approach, which used a 
labeling coil placed at the heart, provided all the benefits of two-coil continuous ASL 
including, high labeling efficiency, ability for multi-slice acquisitions, and lack of 
magnetization transfer artifacts.  
The retina is nourished by two distinct circulations, the retinal vessels within the 
inner retina and the choroid vessels behind the neural retina. These two vascular layers 
are separated by an avascular region of the outer retina. There are substantial differences 
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in basal BF and regulation of BF between the two blood supplies (22,25,26,34,35,37), so 
it is important to be able to distinguish the two vasculatures. The continuous ASL 
technique with cardiac labeling proved capable of imaging cerebral BF in mice with good 
SNR and BF contrast in relatively short time. Thus, this technique was promising for BF 
studies of the mouse retina.  
High-resolution cardiac ASL could image quantitative, layer-specific retinal BF 
(rBF) and choroidal BF (chBF) in the mouse retina in vivo. BF differences due to 
different anesthetics and hypoxic challenge could be detected with MRI. This 
demonstrated for the first time that MRI could be used to image layer-specific blood flow 
to the retina and choroid, providing both basal BF and functional BF changes. 
Quantitative blood flow measurement affords comparison of BF changes between 
experimental groups, facilitating early detection and monitoring of treatment efficacy. 
The BF fMRI technique could provide a means of studying neurovascular coupling of the 
retinal and choroid vessels in disease states as well. 
With the feasibility of layer-specific BF MRI of the retina and choroid having 
been demonstrated in healthy mice, the method was applied to study BF in two retinal 
diseases: diabetic retinopathy and retinal degeneration. Diabetic retinopathy is the leading 
cause of blindness in most developed countries (170,171). Dysfunction of the retinal 
vasculature is the most prominent feature of diabetic retinopathy, signs of which are used 
clinically to diagnosis the disease. ASL MRI was utilized to image quantitative, layer-
specific rBF and chBF in the Ins2
Akita
 mouse model of diabetic retinopathy. The Ins2
Akita
 
mouse has deficient β cells in the pancreas resulting in hypoinsulemia and hyperglycemia 
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(207). Further, the vision of the hyperglycemic mice was studied using psychophysical 
tests to determine changes of visual acuity and contrast sensitivity in diabetic mice (199). 
In aged hyperglycemic mice, rBF was lower and acuity and contrast sensitivity 
were worse, indicating retinopathy. However, the reduction in BF and worsening of 
vision did not seem to be correlated in the hyperglycemic mice, suggesting these changes 
may occur through independent mechanisms. Further studies are needed to determine the 
effects of hyperglycemia at earlier time points and to corroborate the unique BF and 
visual findings in the Ins2
Akita
 mouse. Decreased rBF is consistent with previous studies 
in other animal models of diabetes (30,187,202-204). However, in general the changes in 
retinal and choroidal BF in diabetic retinopathy are complex and remain unclear, with 
conflicting reports finding no changes of BF in diabetics (2,177), increased BF 
(3,178,179), and decreased BF (4). 
Retinitis pigmentosa is the most common inherited form of retinal degeneration, 
affecting 1.5 million people worldwide (215). Retinitis pigmentosa is a group of retinal 
dystrophies that cause photoreceptor death and blindness (216). There is also evidence of 
vascular disruption in the retina (7,10,217), although this factor has not been well studied. 
MRI was utilized to image quantitative, layer-specific retinal and choroidal BF 
and anatomy in the rd10 mouse model of retinal degeneration at different stages of 
degeneration. In the rd10 mice, the retina was much thinner as cellular layers 
degenerated, as detected by anatomical MRI and histology. Retinal BF was found to be 
reduced at later stages of degeneration, while chBF was unaffected in rd10 mice. This is 
in agreement with previous studies of retinal degenerations. In humans, blood flow in 
retinal veins is lower in retinitis pigmentosa patients, as well as total rBF (217). In a cat 
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model of retinitis pigmentosa, rBF is compromised while chBF was not significantly 
affected (7). A study using ASL MRI in a rat model of retinal degeneration showed that 
chBF was not affected, while rBF was decreased (232). These studies demonstrate that 
BF is affected in retinal degeneration, although it is not clear if this is only a side-effect 
of retinal damage or possibly involved in degeneration. 
7.1 Future Work 
 These studies showed the feasibility of using high-resolution MRI to study the 
retina in mice. Although the results demonstrated that MRI could be a useful tool for 
imaging the retina, further improvement of the techniques are necessary. In particular, 
much work remains to further develop and validate ASL MRI to image BF of the retina 
and choroid. MRI was used to acquire unique information about retinal / choroidal BF 
under different anesthetics and disease states. However, no previous reports of retinal and 
choroidal BF differences between isoflurane and ketamine/xylazine, in the Ins2
Akita
 
mouse model of diabetes, or in the rd10 mouse model of retinal degeneration could be 
found for comparison. Therefore, it would help to validate the utility of ASL MRI in the 
retina if these unique findings could be corroborated by other, more established 
techniques, like laser Doppler velocimetry or microspheres. 
There is also much more that could be done to improve the sensitivity and 
quantitative accuracy of MRI BF measurements in the retina. Background suppression 
has been widely utilized in ASL sequences to reduce the noise of the BF signal by 
suppressing the static tissue signal (56). Background suppression was explored to some 
extent in Chapter 3.2, but preliminary results found little improvement in the BF signal, 
so this method was not used in later studies. However, background suppression seems to 
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be important in obtaining layer-specific BF MRI of the rat retina and choroid (232). Also, 
as demonstrated in Chapter 4, EPI is not an ideal sequence for imaging the retina. 
Standard gradient echo and spin echo sequences would not have the speed or signal to 
noise ratio necessary for BF MRI. Alternative sequences that have rapid acquisition, such 
as bSSFP or gradient and spin echo (GRASE), have had promising results in the brain 
and kidneys (235,236). Application of these sequences to acquire ASL data of the retina 
might be another way of improving BF measurements. 
More complicated models to calculate BF have been developed, such as two 
compartment models (73), which account for more parameters. Although more complex 
models might give more accurate BF values, they require the measurement of additional 
parameters used in the calculation, making their implementation difficult. Their 
application to the retina is currently impractical due to the difficulty and long times 
needed to obtain even simple BF measurements. Also determination of the water tissue 
blood partition coefficient for the retina and choroid could possibly be made. The water 
content of the neural retina has been determined (66), so it is possible that similar 
experiments could be performed on the choroid as well. 
Future studies should also look at regulation of rBF and chBF in disease in 
addition to basal BF. Although BF and BOLD fMRI of the retina was detailed in Chapter 
3, the hypoxic stimulation likely provides limited information on the local regulation of 
rBF and chBF. The hypoxic challenge seems to cause large drops in systemic blood 
pressure, which may be the cause of the BF changes of the retina/choroid, rather than 
local vasoconstriction of the two vasculatures. An ideal stimulation should directly cause 
vasoconstriction or dilation of the retinal and choroidal vasculatures without altering the 
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subject’s physiology. Hypercapnic stimulation which is widely used in studies of cerebral 
BF may offer a more relevant stimulation. Preliminary studies of the affect of 
hypercapnia in the mouse retina have shown inconsistency. Some mice show moderate to 
strong changes in rBF and chBF in response to hypercapnia, but others seem to have 
absolutely no BF response to the stimulation. Mechanically ventilating mice and 
monitoring blood gas could possibly provide more stable physiology and give more 
consistent BF changes. Other stimulations, such as pharmacological challenge (for 
example sodium nitroprusside or phenylephrine (237)), could be explored as a means of 
studying BF regulation in the retina and choroid. 
 
MRI has the potential to provide unique, layer-specific information about the 
retina and choroid non-invasively. Although MRI of the retina is difficult and is limited 
by resolution and signal to noise ratio, the studies detailed in this thesis demonstrate the 
feasibility of layer-specific MRI to study anatomy, function, and blood flow of the retina 
in mice. Further, these methods were shown to provide a novel means of studying animal 
models of retinal disease in vivo. Future improvements of MRI techniques should 
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